Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the average magnitude of these risks is uncertain and may depend on the context. Estimates based on multiple-case families may be enriched for mutations of higher risk and/or other familial risk factors, wherea...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of human genetics Vol. 72; no. 5; pp. 1117 - 1130
Main Authors Antoniou, A., Pharoah, P.D.P., Narod, S., Risch, H.A., Eyfjord, J.E., Hopper, J.L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., Pasini, B., Radice, P., Manoukian, S., Eccles, D.M., Tang, N., Olah, E., Anton-Culver, H., Warner, E., Lubinski, J., Gronwald, J., Gorski, B., Tulinius, H., Thorlacius, S., Eerola, H., Nevanlinna, H., Syrjäkoski, K., Kallioniemi, O.-P., Thompson, D., Evans, C., Peto, J., Lalloo, F., Evans, D.G., Easton, D.F.
Format Journal Article
LanguageEnglish
Published Chicago, IL Elsevier Inc 01.05.2003
University of Chicago Press
The American Society of Human Genetics
Subjects
Online AccessGet full text
ISSN0002-9297
1537-6605
1537-6605
DOI10.1086/375033

Cover

Abstract Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the average magnitude of these risks is uncertain and may depend on the context. Estimates based on multiple-case families may be enriched for mutations of higher risk and/or other familial risk factors, whereas risk estimates from studies based on cases unselected for family history have been imprecise. We pooled pedigree data from 22 studies involving 8,139 index case patients unselected for family history with female (86%) or male (2%) breast cancer or epithelial ovarian cancer (12%), 500 of whom had been found to carry a germline mutation in BRCA1 or BRCA2. Breast and ovarian cancer incidence rates for mutation carriers were estimated using a modified segregation analysis, based on the occurrence of these cancers in the relatives of mutation-carrying index case patients. The average cumulative risks in BRCA1-mutation carriers by age 70 years were 65% (95% confidence interval 44%–78%) for breast cancer and 39% (18%–54%) for ovarian cancer. The corresponding estimates for BRCA2 were 45% (31%–56%) and 11% (2.4%–19%). Relative risks of breast cancer declined significantly with age for BRCA1-mutation carriers ( P trend .0012) but not for BRCA2-mutation carriers. Risks in carriers were higher when based on index breast cancer cases diagnosed at <35 years of age. We found some evidence for a reduction in risk in women from earlier birth cohorts and for variation in risk by mutation position for both genes. The pattern of cancer risks was similar to those found in multiple-case families, but their absolute magnitudes were lower, particularly for BRCA2. The variation in risk by age at diagnosis of index case is consistent with the effects of other genes modifying cancer risk in carriers.
AbstractList Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the average magnitude of these risks is uncertain and may depend on the context. Estimates based on multiple-case families may be enriched for mutations of higher risk and/or other familial risk factors, whereas risk estimates from studies based on cases unselected for family history have been imprecise. We pooled pedigree data from 22 studies involving 8,139 index case patients unselected for family history with female (86%) or male (2%) breast cancer or epithelial ovarian cancer (12%), 500 of whom had been found to carry a germline mutation in BRCA1 or BRCA2. Breast and ovarian cancer incidence rates for mutation carriers were estimated using a modified segregation analysis, based on the occurrence of these cancers in the relatives of mutation-carrying index case patients. The average cumulative risks in BRCA1-mutation carriers by age 70 years were 65% (95% confidence interval 44%-78%) for breast cancer and 39% (18%-54%) for ovarian cancer. The corresponding estimates for BRCA2 were 45% (31%-56%) and 11% (2.4%-19%). Relative risks of breast cancer declined significantly with age for BRCA1-mutation carriers ( P trend .0012) but not for BRCA2-mutation carriers. Risks in carriers were higher when based on index breast cancer cases diagnosed at <35 years of age. We found some evidence for a reduction in risk in women from earlier birth cohorts and for variation in risk by mutation position for both genes. The pattern of cancer risks was similar to those found in multiple-case families, but their absolute magnitudes were lower, particularly for BRCA2. The variation in risk by age at diagnosis of index case is consistent with the effects of other genes modifying cancer risk in carriers.
Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the average magnitude of these risks is uncertain and may depend on the context. Estimates based on multiple-case families may be enriched for mutations of higher risk and/or other familial risk factors, whereas risk estimates from studies based on cases unselected for family history have been imprecise. We pooled pedigree data from 22 studies involving 8,139 index case patients unselected for family history with female (86%) or male (2%) breast cancer or epithelial ovarian cancer (12%), 500 of whom had been found to carry a germline mutation in BRCA1 or BRCA2. Breast and ovarian cancer incidence rates for mutation carriers were estimated using a modified segregation analysis, based on the occurrence of these cancers in the relatives of mutation-carrying index case patients. The average cumulative risks in BRCA1-mutation carriers by age 70 years were 65% (95% confidence interval 44%-78%) for breast cancer and 39% (18%-54%) for ovarian cancer. The corresponding estimates for BRCA2 were 45% (31%-56%) and 11% (2.4%-19%). Relative risks of breast cancer declined significantly with age for BRCA1-mutation carriers (P trend.0012) but not for BRCA2-mutation carriers. Risks in carriers were higher when based on index breast cancer cases diagnosed at <35 years of age. We found some evidence for a reduction in risk in women from earlier birth cohorts and for variation in risk by mutation position for both genes. The pattern of cancer risks was similar to those found in multiple-case families, but their absolute magnitudes were lower, particularly for BRCA2. The variation in risk by age at diagnosis of index case is consistent with the effects of other genes modifying cancer risk in carriers.Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the average magnitude of these risks is uncertain and may depend on the context. Estimates based on multiple-case families may be enriched for mutations of higher risk and/or other familial risk factors, whereas risk estimates from studies based on cases unselected for family history have been imprecise. We pooled pedigree data from 22 studies involving 8,139 index case patients unselected for family history with female (86%) or male (2%) breast cancer or epithelial ovarian cancer (12%), 500 of whom had been found to carry a germline mutation in BRCA1 or BRCA2. Breast and ovarian cancer incidence rates for mutation carriers were estimated using a modified segregation analysis, based on the occurrence of these cancers in the relatives of mutation-carrying index case patients. The average cumulative risks in BRCA1-mutation carriers by age 70 years were 65% (95% confidence interval 44%-78%) for breast cancer and 39% (18%-54%) for ovarian cancer. The corresponding estimates for BRCA2 were 45% (31%-56%) and 11% (2.4%-19%). Relative risks of breast cancer declined significantly with age for BRCA1-mutation carriers (P trend.0012) but not for BRCA2-mutation carriers. Risks in carriers were higher when based on index breast cancer cases diagnosed at <35 years of age. We found some evidence for a reduction in risk in women from earlier birth cohorts and for variation in risk by mutation position for both genes. The pattern of cancer risks was similar to those found in multiple-case families, but their absolute magnitudes were lower, particularly for BRCA2. The variation in risk by age at diagnosis of index case is consistent with the effects of other genes modifying cancer risk in carriers.
Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the average magnitude of these risks is uncertain and may depend on the context. Estimates based on multiple-case families may be enriched for mutations of higher risk and/or other familial risk factors, whereas risk estimates from studies based on cases unselected for family history have been imprecise. We pooled pedigree data from 22 studies involving 8,139 index case patients unselected for family history with female (86%) or male (2%) breast cancer or epithelial ovarian cancer (12%), 500 of whom had been found to carry a germline mutation in BRCA1 or BRCA2. Breast and ovarian cancer incidence rates for mutation carriers were estimated using a modified segregation analysis, based on the occurrence of these cancers in the relatives of mutation-carrying index case patients. The average cumulative risks in BRCA1-mutation carriers by age 70 years were 65% (95% confidence interval 44%–78%) for breast cancer and 39% (18%–54%) for ovarian cancer. The corresponding estimates for BRCA2 were 45% (31%–56%) and 11% (2.4%–19%). Relative risks of breast cancer declined significantly with age for BRCA1-mutation carriers ( P trend .0012) but not for BRCA2-mutation carriers. Risks in carriers were higher when based on index breast cancer cases diagnosed at <35 years of age. We found some evidence for a reduction in risk in women from earlier birth cohorts and for variation in risk by mutation position for both genes. The pattern of cancer risks was similar to those found in multiple-case families, but their absolute magnitudes were lower, particularly for BRCA2. The variation in risk by age at diagnosis of index case is consistent with the effects of other genes modifying cancer risk in carriers.
Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the average magnitude of these risks is uncertain and may depend on the context. Estimates based on multiple-case families may be enriched for mutations of higher risk and/or other familial risk factors, whereas risk estimates from studies based on cases unselected for family history have been imprecise. We pooled pedigree data from 22 studies involving 8,139 index case patients unselected for family history with female (86%) or male (2%) breast cancer or epithelial ovarian cancer (12%), 500 of whom had been found to carry a germline mutation in BRCA1 or BRCA2. Breast and ovarian cancer incidence rates for mutation carriers were estimated using a modified segregation analysis, based on the occurrence of these cancers in the relatives of mutation-carrying index case patients. The average cumulative risks in BRCA1- mutation carriers by age 70 years were 65% (95% confidence interval 44%–78%) for breast cancer and 39% (18%–54%) for ovarian cancer. The corresponding estimates for BRCA2 were 45% (31%–56%) and 11% (2.4%–19%). Relative risks of breast cancer declined significantly with age for BRCA1- mutation carriers ( P trend .0012) but not for BRCA2- mutation carriers. Risks in carriers were higher when based on index breast cancer cases diagnosed at <35 years of age. We found some evidence for a reduction in risk in women from earlier birth cohorts and for variation in risk by mutation position for both genes. The pattern of cancer risks was similar to those found in multiple-case families, but their absolute magnitudes were lower, particularly for BRCA2. The variation in risk by age at diagnosis of index case is consistent with the effects of other genes modifying cancer risk in carriers.
Author Eyfjord, J.E.
Thorlacius, S.
Johannsson, O.
Hopper, J.L.
Loman, N.
Evans, D.G.
Pasini, B.
Manoukian, S.
Tulinius, H.
Tang, N.
Olah, E.
Anton-Culver, H.
Easton, D.F.
Eerola, H.
Nevanlinna, H.
Syrjäkoski, K.
Thompson, D.
Pharoah, P.D.P.
Antoniou, A.
Warner, E.
Kallioniemi, O.-P.
Gronwald, J.
Radice, P.
Evans, C.
Eccles, D.M.
Lalloo, F.
Gorski, B.
Narod, S.
Borg, Å.
Lubinski, J.
Risch, H.A.
Peto, J.
Olsson, H.
AuthorAffiliation 1 Cancer Research U.K. Genetic Epidemiology Unit, Department of Public Health, and 2 Cancer Research U.K. Human Cancer Genetics Group, Department of Oncology, University of Cambridge, Cambridge, United Kingdom; 3 Centre for Research on Women’s Health, University of Toronto, Toronto; 4 Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT; 5 Icelandic Cancer Society and 6 University of Iceland, Reykjavík; 7 Centre for Genetic Epidemiology, Department of Public Health, The University of Melbourne, Melbourne; 8 Department of Oncology, Jubileum Institute, Lund University Hospital, Lund, Sweden; 9 National Cancer Institute and 10 FIRC Institute of Molecular Oncology, Milan; 11 Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom; 12 Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong; 13 National Institute of Oncology, Budapest; 14 Epidemiology Division, Department of Medicine, University
AuthorAffiliation_xml – name: 1 Cancer Research U.K. Genetic Epidemiology Unit, Department of Public Health, and 2 Cancer Research U.K. Human Cancer Genetics Group, Department of Oncology, University of Cambridge, Cambridge, United Kingdom; 3 Centre for Research on Women’s Health, University of Toronto, Toronto; 4 Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT; 5 Icelandic Cancer Society and 6 University of Iceland, Reykjavík; 7 Centre for Genetic Epidemiology, Department of Public Health, The University of Melbourne, Melbourne; 8 Department of Oncology, Jubileum Institute, Lund University Hospital, Lund, Sweden; 9 National Cancer Institute and 10 FIRC Institute of Molecular Oncology, Milan; 11 Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom; 12 Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong; 13 National Institute of Oncology, Budapest; 14 Epidemiology Division, Department of Medicine, University of California, Irvine; 15 Hereditary Cancer Centre, Department of Genetics and Pathology, Pomeranian Academy of Medicine, Szczecin, Poland; Departments of 16 Obstetrics and Gynecology and 17 Oncology, Helsinki University Central Hospital, Helsinki; 18 Laboratory of Cancer Genetics, Institute of Medical Technology, Tampere University and Tampere University Hospital, Tampere, Finland; 19 Section of Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 20 London School of Hygiene and Tropical Medicine, London; and 21 Academic Unit of Medical Genetics and Regional Genetics Service, St. Mary’s Hospital, Manchester, United Kingdom
Author_xml – sequence: 1
  givenname: A.
  surname: Antoniou
  fullname: Antoniou, A.
  organization: Cancer Research U.K. Genetic Epidemiology Unit, Department of Public Health
– sequence: 2
  givenname: P.D.P.
  surname: Pharoah
  fullname: Pharoah, P.D.P.
  email: paul.pharoah@srl.cam.ac.uk
  organization: Cancer Research U.K. Human Cancer Genetics Group, Department of Oncology, University of Cambridge, Cambridge, United Kingdom
– sequence: 3
  givenname: S.
  surname: Narod
  fullname: Narod, S.
  organization: Centre for Research on Women’s Health, University of Toronto, Toronto
– sequence: 4
  givenname: H.A.
  surname: Risch
  fullname: Risch, H.A.
  organization: Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT
– sequence: 5
  givenname: J.E.
  surname: Eyfjord
  fullname: Eyfjord, J.E.
  organization: Icelandic Cancer Society and University of Iceland
– sequence: 6
  givenname: J.L.
  surname: Hopper
  fullname: Hopper, J.L.
  organization: Centre for Genetic Epidemiology, Department of Public Health, The University of Melbourne, Melbourne
– sequence: 7
  givenname: N.
  surname: Loman
  fullname: Loman, N.
  organization: Department of Oncology, Jubileum Institute, Lund University Hospital, Lund, Sweden
– sequence: 8
  givenname: H.
  surname: Olsson
  fullname: Olsson, H.
  organization: Department of Oncology, Jubileum Institute, Lund University Hospital, Lund, Sweden
– sequence: 9
  givenname: O.
  surname: Johannsson
  fullname: Johannsson, O.
  organization: Department of Oncology, Jubileum Institute, Lund University Hospital, Lund, Sweden
– sequence: 10
  givenname: Å.
  surname: Borg
  fullname: Borg, Å.
  organization: Department of Oncology, Jubileum Institute, Lund University Hospital, Lund, Sweden
– sequence: 11
  givenname: B.
  surname: Pasini
  fullname: Pasini, B.
  organization: National Cancer Institute
– sequence: 12
  givenname: P.
  surname: Radice
  fullname: Radice, P.
  organization: National Cancer Institute
– sequence: 13
  givenname: S.
  surname: Manoukian
  fullname: Manoukian, S.
  organization: National Cancer Institute
– sequence: 14
  givenname: D.M.
  surname: Eccles
  fullname: Eccles, D.M.
  organization: Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom
– sequence: 15
  givenname: N.
  surname: Tang
  fullname: Tang, N.
  organization: Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong
– sequence: 16
  givenname: E.
  surname: Olah
  fullname: Olah, E.
  organization: National Institute of Oncology, Budapest
– sequence: 17
  givenname: H.
  surname: Anton-Culver
  fullname: Anton-Culver, H.
  organization: Epidemiology Division, Department of Medicine, University of California, Irvine
– sequence: 18
  givenname: E.
  surname: Warner
  fullname: Warner, E.
  organization: Centre for Research on Women’s Health, University of Toronto, Toronto
– sequence: 19
  givenname: J.
  surname: Lubinski
  fullname: Lubinski, J.
  organization: Hereditary Cancer Centre, Department of Genetics and Pathology, Pomeranian Academy of Medicine, Szczecin, Poland
– sequence: 20
  givenname: J.
  surname: Gronwald
  fullname: Gronwald, J.
  organization: Hereditary Cancer Centre, Department of Genetics and Pathology, Pomeranian Academy of Medicine, Szczecin, Poland
– sequence: 21
  givenname: B.
  surname: Gorski
  fullname: Gorski, B.
  organization: Hereditary Cancer Centre, Department of Genetics and Pathology, Pomeranian Academy of Medicine, Szczecin, Poland
– sequence: 22
  givenname: H.
  surname: Tulinius
  fullname: Tulinius, H.
  organization: Icelandic Cancer Society and University of Iceland
– sequence: 23
  givenname: S.
  surname: Thorlacius
  fullname: Thorlacius, S.
  organization: Icelandic Cancer Society and University of Iceland
– sequence: 24
  givenname: H.
  surname: Eerola
  fullname: Eerola, H.
  organization: Departments of Obstetrics and
– sequence: 25
  givenname: H.
  surname: Nevanlinna
  fullname: Nevanlinna, H.
  organization: Departments of Obstetrics and
– sequence: 26
  givenname: K.
  surname: Syrjäkoski
  fullname: Syrjäkoski, K.
  organization: Laboratory of Cancer Genetics, Institute of Medical Technology, Tampere University and Tampere University Hospital, Tampere, Finland
– sequence: 27
  givenname: O.-P.
  surname: Kallioniemi
  fullname: Kallioniemi, O.-P.
  organization: Laboratory of Cancer Genetics, Institute of Medical Technology, Tampere University and Tampere University Hospital, Tampere, Finland
– sequence: 28
  givenname: D.
  surname: Thompson
  fullname: Thompson, D.
  organization: Cancer Research U.K. Genetic Epidemiology Unit, Department of Public Health
– sequence: 29
  givenname: C.
  surname: Evans
  fullname: Evans, C.
  organization: Cancer Research U.K. Genetic Epidemiology Unit, Department of Public Health
– sequence: 30
  givenname: J.
  surname: Peto
  fullname: Peto, J.
  organization: Section of Epidemiology, Institute of Cancer Research, Sutton, United Kingdom
– sequence: 31
  givenname: F.
  surname: Lalloo
  fullname: Lalloo, F.
  organization: Academic Unit of Medical Genetics and Regional Genetics Service, St. Mary’s Hospital, Manchester, United Kingdom
– sequence: 32
  givenname: D.G.
  surname: Evans
  fullname: Evans, D.G.
  organization: Academic Unit of Medical Genetics and Regional Genetics Service, St. Mary’s Hospital, Manchester, United Kingdom
– sequence: 33
  givenname: D.F.
  surname: Easton
  fullname: Easton, D.F.
  organization: Cancer Research U.K. Genetic Epidemiology Unit, Department of Public Health
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14804286$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/12677558$$D View this record in MEDLINE/PubMed
BookMark eNplklFv0zAUhSM0xLoBPwH5BZ4oOLbjpDxMygpjSEOTNvZs3Tg3qyGNi2_Sqf-JH4m7FMrGky3d75xj656j5KDzHSbJy5S_S3mh38s841I-SSZpJvOp1jw7SCacczGdiVl-mBwRfec8TQsunyWHqdB5nmXFJPlVrjHALbIrRz-I-YadBgTqGXQ1u1xDcNCxOXQWAyuJvHXQY83uXL9gp1fzMmU-3F8E-zr00DvfEfuIPdot5rZaQnaNwSGxm46wHSdNlJ3B0rUbdu6o92HzgZVs7peV6-K47KDdkLt_kBDsuh_qaPA8edpAS_hidx4nN2efvs3PpxeXn7_My4upzYTspwKsalSmoLJaVVoIVVU2r5XSFee5kqqxSgqQuqit1RlgYTNVp7ktskJUWMvjBEZfusPVUJlVcEsIG-PBmZUPPbQmICEEuzDtYAhNpFpnx-8bOZMaJEqTNsCNSmfazKSqTCpmmld5JptKxYyTMSNKl1hb7PoQfR9EPZh0bmFu_dpsdyh0Fg3e7AyC_zkg9WbpyGLbQod-IJNLEdFURvDVv0l_I_6UIAKvdwCQhbYJcd2O9pwquBKF3ifa4IkCNnuEm20LzdjCCL59BFo3diP-xLX_43zEMe507TAYsg5j5WoXYltM7d1jyW8tYO3q
CODEN AJHGAG
CitedBy_id crossref_primary_10_1086_424388
crossref_primary_10_1371_journal_pone_0156661
crossref_primary_10_1002_cncr_21479
crossref_primary_10_1002_ijc_32918
crossref_primary_10_1002_jgc4_1374
crossref_primary_10_1002_gcc_20723
crossref_primary_10_1158_1078_0432_CCR_17_2136
crossref_primary_10_1007_s10897_007_9102_7
crossref_primary_10_1371_journal_pone_0178450
crossref_primary_10_1200_JCO_2005_10_035
crossref_primary_10_1016_j_ygyno_2021_03_030
crossref_primary_10_1186_1471_2407_8_140
crossref_primary_10_1160_th15_06_0520
crossref_primary_10_1016_j_breast_2016_07_007
crossref_primary_10_1080_07357907_2017_1289217
crossref_primary_10_1177_0306312709103501
crossref_primary_10_1186_1471_2407_8_146
crossref_primary_10_1016_j_clon_2024_08_006
crossref_primary_10_1016_j_ccm_2011_08_017
crossref_primary_10_1186_1471_2350_7_75
crossref_primary_10_1007_s10689_016_9873_9
crossref_primary_10_1002_pd_1925
crossref_primary_10_1007_s11764_016_0582_z
crossref_primary_10_1097_GRF_0000000000000893
crossref_primary_10_1097_GRF_0000000000000897
crossref_primary_10_1016_j_ejca_2003_09_016
crossref_primary_10_1007_s10689_015_9817_9
crossref_primary_10_1631_jzus_B073001
crossref_primary_10_3390_ijerph16234793
crossref_primary_10_1093_annonc_mdw209
crossref_primary_10_1136_bmjopen_2018_021782
crossref_primary_10_1016_j_cca_2020_12_001
crossref_primary_10_1093_humrep_des441
crossref_primary_10_1016_j_acra_2015_11_011
crossref_primary_10_1179_096992604225005263
crossref_primary_10_1186_bcr3369
crossref_primary_10_1016_j_ygyno_2004_06_031
crossref_primary_10_1002_humu_20599
crossref_primary_10_1007_s10549_006_9220_1
crossref_primary_10_1007_s10689_004_9554_y
crossref_primary_10_1208_s12249_019_1468_y
crossref_primary_10_1038_s41416_019_0484_8
crossref_primary_10_1042_BJ20141077
crossref_primary_10_4161_cc_22776
crossref_primary_10_7314_APJCP_2012_13_5_2241
crossref_primary_10_1159_000353786
crossref_primary_10_1089_gtmb_2017_0187
crossref_primary_10_1200_JCO_2016_70_3439
crossref_primary_10_1093_annonc_mdm537
crossref_primary_10_1016_j_compbiolchem_2018_10_012
crossref_primary_10_18632_oncotarget_12158
crossref_primary_10_1111_jfb_13168
crossref_primary_10_1186_s13048_017_0355_y
crossref_primary_10_3390_genes13081399
crossref_primary_10_1016_j_ejso_2024_109380
crossref_primary_10_1016_j_anndiagpath_2018_06_003
crossref_primary_10_1016_j_ntm_2024_100047
crossref_primary_10_1383_wohm_2006_3_1_8
crossref_primary_10_1097_MD_0000000000034428
crossref_primary_10_1016_j_anplas_2016_02_002
crossref_primary_10_1038_s41598_022_25511_9
crossref_primary_10_1002_jgc4_1361
crossref_primary_10_1007_s10549_009_0607_7
crossref_primary_10_1016_j_bpobgyn_2020_01_006
crossref_primary_10_1001_jama_2019_8430
crossref_primary_10_3389_fonc_2020_574813
crossref_primary_10_1111_j_1365_2265_2006_02713_x
crossref_primary_10_2196_cancer_9210
crossref_primary_10_1002_ibd_21883
crossref_primary_10_1159_000343976
crossref_primary_10_1155_2016_7869095
crossref_primary_10_3390_ijms23010348
crossref_primary_10_3390_jcm11247502
crossref_primary_10_1038_bjc_2015_208
crossref_primary_10_1016_j_ygyno_2015_04_029
crossref_primary_10_1159_000091305
crossref_primary_10_1007_s10549_020_06072_9
crossref_primary_10_1002_ijgo_12447
crossref_primary_10_1038_sj_bjc_6605876
crossref_primary_10_1007_s10689_015_9785_0
crossref_primary_10_1371_journal_pgen_1007752
crossref_primary_10_4132_jptm_2022_05_02
crossref_primary_10_1186_0778_7367_69_8
crossref_primary_10_1186_s12894_016_0130_1
crossref_primary_10_3390_cancers10120487
crossref_primary_10_1007_s10549_016_3686_2
crossref_primary_10_2217_fon_09_29
crossref_primary_10_1111_j_1365_2559_2010_03724_x
crossref_primary_10_1200_JCO_2014_59_0463
crossref_primary_10_1016_S1470_2045_06_70983_4
crossref_primary_10_1371_journal_pone_0293422
crossref_primary_10_1007_s10549_023_07074_z
crossref_primary_10_1016_j_eururo_2019_08_025
crossref_primary_10_1186_1897_4287_2_4_185
crossref_primary_10_1016_j_amjsurg_2024_116005
crossref_primary_10_1200_JCO_2013_48_9021
crossref_primary_10_1016_j_breast_2017_02_008
crossref_primary_10_1016_j_clbc_2018_02_007
crossref_primary_10_1158_1055_9965_EPI_09_0107
crossref_primary_10_1371_journal_pone_0158801
crossref_primary_10_1016_j_ygyno_2005_01_039
crossref_primary_10_1159_000368836
crossref_primary_10_1002_gcc_22921
crossref_primary_10_1177_000313481808400139
crossref_primary_10_1007_s10549_010_1325_x
crossref_primary_10_1016_j_cancergen_2019_10_004
crossref_primary_10_1016_j_maturitas_2011_08_001
crossref_primary_10_1016_S1472_6483_10_60274_X
crossref_primary_10_1038_sj_bjc_6605416
crossref_primary_10_1038_ejhg_2011_146
crossref_primary_10_1177_1090198105278758
crossref_primary_10_1038_sj_bjc_6602389
crossref_primary_10_1051_medsci_2004203262
crossref_primary_10_1089_gte_2008_0067
crossref_primary_10_1016_j_ejmech_2020_112635
crossref_primary_10_1097_NCC_0b013e3182642cb5
crossref_primary_10_1111_1471_0528_15471
crossref_primary_10_1158_1940_6207_CAPR_20_0411
crossref_primary_10_1158_1940_6207_CAPR_20_0407
crossref_primary_10_1186_s13058_016_0759_4
crossref_primary_10_1016_j_breast_2021_09_006
crossref_primary_10_1148_radiol_2463070224
crossref_primary_10_3390_cancers13112729
crossref_primary_10_1200_JCO_2005_10_042
crossref_primary_10_1002_cncr_22352
crossref_primary_10_1002_jgc4_1322
crossref_primary_10_1371_journal_pgen_1001183
crossref_primary_10_3390_healthcare3040948
crossref_primary_10_3390_cancers14102350
crossref_primary_10_3892_ol_2017_6149
crossref_primary_10_1136_bmjopen_2023_076876
crossref_primary_10_1016_j_ygyno_2016_01_019
crossref_primary_10_1016_j_hpr_2024_300764
crossref_primary_10_1007_s00129_009_2424_9
crossref_primary_10_1007_s00761_008_1471_5
crossref_primary_10_3390_jpm12060959
crossref_primary_10_5812_ijcm_60392
crossref_primary_10_1097_gme_0b013e3181ecfb51
crossref_primary_10_1023_B_JOGC_0000018822_56297_a6
crossref_primary_10_1016_j_fertnstert_2019_07_1349
crossref_primary_10_1002_ijc_28014
crossref_primary_10_1684_bdc_2013_1708
crossref_primary_10_1002_ijc_29347
crossref_primary_10_1021_mp500628g
crossref_primary_10_1016_j_critrevonc_2018_05_008
crossref_primary_10_1007_s10689_010_9361_6
crossref_primary_10_1111_cas_13307
crossref_primary_10_1093_nar_gkx1280
crossref_primary_10_1126_science_1216823
crossref_primary_10_1007_s10904_017_0661_2
crossref_primary_10_1016_S1550_8579_07_80039_8
crossref_primary_10_3390_cancers17010039
crossref_primary_10_1080_10810730_2019_1604912
crossref_primary_10_1016_j_neo_2020_09_009
crossref_primary_10_1177_00031348241265145
crossref_primary_10_1016_j_celrep_2025_115259
crossref_primary_10_1016_j_gyobfe_2005_09_017
crossref_primary_10_3802_jgo_2018_29_e43
crossref_primary_10_1158_1055_9965_EPI_06_0258
crossref_primary_10_1007_s10689_013_9620_4
crossref_primary_10_1038_s41598_018_27315_2
crossref_primary_10_1002_gcc_20330
crossref_primary_10_1038_s41467_021_26079_0
crossref_primary_10_1007_s00251_011_0564_2
crossref_primary_10_3802_jgo_2024_35_e51
crossref_primary_10_1016_j_breast_2016_05_012
crossref_primary_10_1126_science_306_5705_2187c
crossref_primary_10_1159_000352028
crossref_primary_10_1517_14656566_7_18_2455
crossref_primary_10_1007_s40291_020_00489_0
crossref_primary_10_1111_cge_12747
crossref_primary_10_17650_1994_4098_2022_18_4_32_37
crossref_primary_10_1016_j_cpet_2009_09_003
crossref_primary_10_1016_j_critrevonc_2018_10_012
crossref_primary_10_1186_1471_2350_14_82
crossref_primary_10_1007_s10549_018_5035_0
crossref_primary_10_1007_s12609_014_0145_0
crossref_primary_10_1007_s10549_015_3674_y
crossref_primary_10_1038_ng_893
crossref_primary_10_1016_j_suc_2007_01_009
crossref_primary_10_1016_j_ajhg_2011_04_001
crossref_primary_10_1007_s10549_012_2022_8
crossref_primary_10_1053_j_seminoncol_2020_05_008
crossref_primary_10_1089_gtmb_2017_0104
crossref_primary_10_1093_jnci_djn313
crossref_primary_10_1093_narcan_zcae044
crossref_primary_10_1186_1471_2407_14_221
crossref_primary_10_1016_j_lpm_2006_12_003
crossref_primary_10_1067_j_cpsurg_2010_06_002
crossref_primary_10_1200_EDBK_433576
crossref_primary_10_1186_1897_4287_12_11
crossref_primary_10_1007_s10689_010_9383_0
crossref_primary_10_1136_bmjopen_2018_023115
crossref_primary_10_1177_030089160609200609
crossref_primary_10_1002_14651858_CD012894
crossref_primary_10_1016_j_maturitas_2017_06_002
crossref_primary_10_1186_1472_6874_12_12
crossref_primary_10_1016_j_maturitas_2017_06_003
crossref_primary_10_1007_s00292_010_1355_5
crossref_primary_10_1016_j_maturitas_2013_09_012
crossref_primary_10_1186_1742_5573_8_2
crossref_primary_10_1093_jnci_djt095
crossref_primary_10_1136_bmjopen_2019_031031
crossref_primary_10_1007_s00439_009_0774_y
crossref_primary_10_1016_j_annonc_2021_11_013
crossref_primary_10_1007_s10549_009_0566_z
crossref_primary_10_1155_2013_747318
crossref_primary_10_1093_annonc_mdr373
crossref_primary_10_3390_medsci13010024
crossref_primary_10_3238_arztebl_2011_0323
crossref_primary_10_3390_genes12091371
crossref_primary_10_5468_ogs_2015_58_2_175
crossref_primary_10_1038_s41598_023_27637_w
crossref_primary_10_1002_bies_201500093
crossref_primary_10_1111_j_1751_486X_2008_00383_x
crossref_primary_10_1186_bcr2099
crossref_primary_10_1016_j_breast_2013_07_045
crossref_primary_10_3390_jcm12041524
crossref_primary_10_1016_j_critrevonc_2015_07_010
crossref_primary_10_1089_bio_2020_0002
crossref_primary_10_1136_ijgc_00009577_200601000_00030
crossref_primary_10_1186_s12885_019_6277_x
crossref_primary_10_17116_medtech20244601191
crossref_primary_10_1186_s40659_017_0139_2
crossref_primary_10_1136_ijgc_2021_003153
crossref_primary_10_1007_s10147_015_0906_4
crossref_primary_10_1007_s10911_011_9204_6
crossref_primary_10_1001_jamanetworkopen_2021_43730
crossref_primary_10_1016_S1283_081X_20_43722_1
crossref_primary_10_1016_j_critrevonc_2016_02_014
crossref_primary_10_1017_S0954422413000024
crossref_primary_10_1146_annurev_animal_021815_111406
crossref_primary_10_1002_ijc_29386
crossref_primary_10_1097_IGC_0000000000001161
crossref_primary_10_1155_2013_260847
crossref_primary_10_1007_s10549_025_07643_4
crossref_primary_10_1093_jnci_djv214
crossref_primary_10_1002_jgc4_1734
crossref_primary_10_3390_genes16010082
crossref_primary_10_1186_1471_2407_8_101
crossref_primary_10_1200_JCO_2004_06_090
crossref_primary_10_1002_prot_22460
crossref_primary_10_1157_13100569
crossref_primary_10_1177_1049732318785372
crossref_primary_10_1136_bmjopen_2022_066728
crossref_primary_10_3390_cancers11050707
crossref_primary_10_1038_ncponc0930
crossref_primary_10_1200_JCO_2005_02_626
crossref_primary_10_1016_j_ygyno_2014_09_009
crossref_primary_10_1007_s10549_010_0830_2
crossref_primary_10_1002_iub_2145
crossref_primary_10_1007_s10689_012_9585_8
crossref_primary_10_3389_fonc_2021_662055
crossref_primary_10_3917_sss_261_0033
crossref_primary_10_1158_0008_5472_417_65_2
crossref_primary_10_1016_j_pharmthera_2013_11_010
crossref_primary_10_1007_s12687_016_0266_4
crossref_primary_10_1097_IGC_0000000000001160
crossref_primary_10_1093_jnci_dju379
crossref_primary_10_1007_s11356_019_04228_9
crossref_primary_10_1200_EDBK_160391
crossref_primary_10_2217_bmt_2016_0020
crossref_primary_10_1371_journal_pone_0057781
crossref_primary_10_1002_ijc_23615
crossref_primary_10_1007_s10897_009_9267_3
crossref_primary_10_1111_j_1365_2354_2009_01067_x
crossref_primary_10_1007_s10689_011_9484_4
crossref_primary_10_1007_s13187_015_0950_9
crossref_primary_10_1371_journal_pone_0093400
crossref_primary_10_1007_s10897_013_9625_z
crossref_primary_10_1016_j_jmig_2017_10_025
crossref_primary_10_1111_j_1399_0004_2005_00483_x
crossref_primary_10_1186_1897_4287_2_1_11
crossref_primary_10_1002_0471142905_hg0915s42
crossref_primary_10_1002_cam4_2000
crossref_primary_10_1371_journal_pone_0136192
crossref_primary_10_3390_genes12040519
crossref_primary_10_1007_s10689_011_9418_1
crossref_primary_10_1016_S0716_8640_10_70599_X
crossref_primary_10_3389_fonc_2023_1160370
crossref_primary_10_57187_smw_2023_40055
crossref_primary_10_1007_s10549_010_1080_z
crossref_primary_10_1016_j_cancergen_2017_02_001
crossref_primary_10_1111_j_1539_6975_2007_00202_x
crossref_primary_10_1007_s40291_017_0288_6
crossref_primary_10_1186_bcr3392
crossref_primary_10_3892_mmr_2017_6947
crossref_primary_10_1200_JCO_2006_07_4922
crossref_primary_10_1186_s12885_023_11328_w
crossref_primary_10_1093_jnci_djj392
crossref_primary_10_1210_jc_2017_00765
crossref_primary_10_3389_fonc_2020_00301
crossref_primary_10_1186_1897_4287_2_1_19
crossref_primary_10_1007_s11864_007_0021_5
crossref_primary_10_3390_cancers11091246
crossref_primary_10_1080_15384101_2019_1638192
crossref_primary_10_1016_j_arcmed_2014_06_004
crossref_primary_10_1186_1755_8794_4_75
crossref_primary_10_1038_s41591_019_0422_6
crossref_primary_10_1007_s10897_017_0125_4
crossref_primary_10_1136_ijgc_2022_003893
crossref_primary_10_1158_1055_9965_EPI_08_0795
crossref_primary_10_1371_journal_pone_0001206
crossref_primary_10_1590_S1415_47572012000400009
crossref_primary_10_1245_s10434_016_5545_0
crossref_primary_10_1111_j_1471_0528_2011_03257_x
crossref_primary_10_1158_1078_0432_CCR_19_0419
crossref_primary_10_1245_s10434_012_2258_x
crossref_primary_10_1016_j_trecan_2018_09_002
crossref_primary_10_7326_AITC202311210
crossref_primary_10_1016_S1283_081X_13_64078_3
crossref_primary_10_1038_s41467_023_42830_1
crossref_primary_10_1177_0960327120911426
crossref_primary_10_1093_annonc_mdh657
crossref_primary_10_1158_0008_5472_CAN_08_1560
crossref_primary_10_1200_JCO_2008_16_8310
crossref_primary_10_2217_fon_10_5
crossref_primary_10_1093_annonc_mdh651
crossref_primary_10_1111_1471_0528_14603
crossref_primary_10_1007_s10689_013_9686_z
crossref_primary_10_1016_j_jncc_2022_12_001
crossref_primary_10_1016_j_soncn_2015_02_007
crossref_primary_10_1146_annurev_genom_9_081307_164339
crossref_primary_10_1002_med_21549
crossref_primary_10_1080_10810730_2022_2131941
crossref_primary_10_1086_521032
crossref_primary_10_1007_s10549_008_9977_5
crossref_primary_10_1158_0008_5472_CAN_09_3232
crossref_primary_10_1186_bcr1630
crossref_primary_10_1016_j_pec_2005_08_012
crossref_primary_10_1186_s40659_017_0140_9
crossref_primary_10_1007_s10549_008_0095_1
crossref_primary_10_18332_ejm_171999
crossref_primary_10_18632_oncotarget_21872
crossref_primary_10_1038_bjc_2014_391
crossref_primary_10_1300_J077v22n03_05
crossref_primary_10_1007_s12282_020_01157_1
crossref_primary_10_1038_s10038_022_01077_2
crossref_primary_10_1080_17512433_2018_1513321
crossref_primary_10_1186_s13058_023_01673_w
crossref_primary_10_1002_ijc_33457
crossref_primary_10_3389_fonc_2023_1162644
crossref_primary_10_1245_s10434_019_08157_2
crossref_primary_10_1007_s10897_010_9317_x
crossref_primary_10_1016_j_clbc_2020_11_002
crossref_primary_10_1016_j_ygyno_2019_01_018
crossref_primary_10_1007_s10549_013_2564_4
crossref_primary_10_3390_genes11111251
crossref_primary_10_1038_sj_ejhg_5201256
crossref_primary_10_18632_aging_101082
crossref_primary_10_5306_wjco_v12_i7_544
crossref_primary_10_1007_s00404_013_3022_6
crossref_primary_10_1111_evo_12809
crossref_primary_10_1186_1472_6874_9_20
crossref_primary_10_1016_j_maturitas_2017_08_004
crossref_primary_10_1017_S1748499520000226
crossref_primary_10_1200_OA_24_00079
crossref_primary_10_1016_j_patbio_2006_02_002
crossref_primary_10_2214_AJR_09_3669
crossref_primary_10_3109_09513590_2010_487609
crossref_primary_10_1016_j_amjsurg_2018_02_010
crossref_primary_10_1016_j_path_2010_12_009
crossref_primary_10_21518_2079_701X_2021_9_34_41
crossref_primary_10_2217_fon_15_187
crossref_primary_10_1002_gcc_20381
crossref_primary_10_1016_j_path_2010_12_003
crossref_primary_10_1007_s10689_005_2570_8
crossref_primary_10_1200_JCO_2006_09_1066
crossref_primary_10_1053_j_ro_2018_08_002
crossref_primary_10_1097_PAS_0b013e31819e986a
crossref_primary_10_1007_s10689_009_9235_y
crossref_primary_10_1007_s10549_007_9525_8
crossref_primary_10_1097_gme_0b013e31820246da
crossref_primary_10_1093_annonc_mdp116
crossref_primary_10_1093_carcin_bgaa050
crossref_primary_10_1200_JCO_2011_41_0027
crossref_primary_10_1016_j_molonc_2009_01_008
crossref_primary_10_1155_2010_604304
crossref_primary_10_1002_cncr_27556
crossref_primary_10_1007_s10689_004_5812_2
crossref_primary_10_1186_s12885_018_4366_x
crossref_primary_10_4132_jptm_2020_04_07
crossref_primary_10_1007_s10549_009_0611_y
crossref_primary_10_1093_jnci_djz241
crossref_primary_10_3390_genes11111272
crossref_primary_10_1038_s41416_023_02503_8
crossref_primary_10_1111_j_1399_0004_2011_01774_x
crossref_primary_10_17650_1994_4098_2018_14_3_25_39
crossref_primary_10_1016_j_mpdhp_2009_09_001
crossref_primary_10_1002_cncr_29321
crossref_primary_10_5306_wjco_v12_i7_565
crossref_primary_10_1007_s12032_018_1085_8
crossref_primary_10_1007_s40944_015_0018_0
crossref_primary_10_2478_rrlm_2020_0026
crossref_primary_10_1007_s11845_020_02174_x
crossref_primary_10_6004_jnccn_2021_0001
crossref_primary_10_1080_07347330802359776
crossref_primary_10_1081_CNV_58819
crossref_primary_10_5468_ogs_2017_60_5_477
crossref_primary_10_1186_bcr2919
crossref_primary_10_1200_JCO_19_03120
crossref_primary_10_1016_j_canrad_2011_10_014
crossref_primary_10_1055_s_0041_1734342
crossref_primary_10_1245_s10434_022_11756_1
crossref_primary_10_2147_PGPM_S233485
crossref_primary_10_1007_s10689_007_9171_7
crossref_primary_10_1016_j_cancergen_2012_01_008
crossref_primary_10_1016_j_gene_2012_02_010
crossref_primary_10_1186_s12916_022_02489_9
crossref_primary_10_1002_elan_201400507
crossref_primary_10_1007_s11033_011_0829_8
crossref_primary_10_1038_s41598_019_46707_6
crossref_primary_10_1002_jso_25645
crossref_primary_10_3390_genes14020262
crossref_primary_10_1038_s41598_020_60149_5
crossref_primary_10_1002_ijc_33498
crossref_primary_10_1016_j_jradnu_2017_07_001
crossref_primary_10_1016_j_jval_2017_01_006
crossref_primary_10_1038_s41598_021_85899_8
crossref_primary_10_1002_pon_2041
crossref_primary_10_1016_j_jval_2017_01_004
crossref_primary_10_1093_nutrit_nuw010
crossref_primary_10_1097_01720610_200909000_00018
crossref_primary_10_1200_JCO_2004_01_926
crossref_primary_10_1016_j_ejca_2006_05_032
crossref_primary_10_1097_AOG_0000000000003729
crossref_primary_10_1016_j_drup_2015_09_001
crossref_primary_10_1007_s12609_012_0086_4
crossref_primary_10_1177_1559827613508367
crossref_primary_10_1016_j_ygyno_2012_04_046
crossref_primary_10_17650_1994_4098_2023_19_2_16_24
crossref_primary_10_1007_s10689_009_9311_3
crossref_primary_10_1002_cncr_24086
crossref_primary_10_1200_JCO_2007_13_9626
crossref_primary_10_1007_s10549_010_1120_8
crossref_primary_10_1155_2016_5623089
crossref_primary_10_1016_j_ipm_2013_06_002
crossref_primary_10_1007_s12282_016_0693_4
crossref_primary_10_1016_j_amjsurg_2013_08_002
crossref_primary_10_1093_tbm_ibac031
crossref_primary_10_1038_nrclinonc_2013_174
crossref_primary_10_1007_s12483_011_0003_y
crossref_primary_10_1186_s12885_016_2472_1
crossref_primary_10_18632_oncotarget_18280
crossref_primary_10_3389_fonc_2021_655709
crossref_primary_10_3802_jgo_2020_31_e83
crossref_primary_10_1002_jso_26994
crossref_primary_10_1038_ejhg_2015_268
crossref_primary_10_4236_ojepi_2016_63019
crossref_primary_10_1016_j_ctrv_2018_12_002
crossref_primary_10_1158_0008_5472_CAN_07_0465
crossref_primary_10_3389_fonc_2020_591739
crossref_primary_10_1002_ijc_32184
crossref_primary_10_1186_1897_4287_7_13
crossref_primary_10_23736_S0026_4784_20_04624_9
crossref_primary_10_1111_j_1399_0004_2012_01878_x
crossref_primary_10_1155_2014_875029
crossref_primary_10_1016_j_ejca_2009_03_008
crossref_primary_10_3816_CBC_2004_n_029
crossref_primary_10_1200_JCO_2007_11_3449
crossref_primary_10_1002_humu_23113
crossref_primary_10_1016_j_clbc_2024_01_001
crossref_primary_10_1016_j_soncn_2008_08_005
crossref_primary_10_1186_1471_2350_11_20
crossref_primary_10_1021_jm500415t
crossref_primary_10_1097_GME_0000000000002201
crossref_primary_10_1016_j_ygyno_2015_11_016
crossref_primary_10_17650_1726_9776_2021_17_1_82_88
crossref_primary_10_1007_s10549_013_2823_4
crossref_primary_10_1002_cncr_32536
crossref_primary_10_1002_cncr_33866
crossref_primary_10_1016_S1470_2045_05_70390_9
crossref_primary_10_1007_s40142_019_00168_5
crossref_primary_10_1007_s00404_017_4529_z
crossref_primary_10_1002_ijc_28941
crossref_primary_10_1007_s10549_008_0064_8
crossref_primary_10_1007_s40944_017_0100_x
crossref_primary_10_1016_j_breast_2010_05_009
crossref_primary_10_1007_s12094_008_0160_6
crossref_primary_10_1016_j_ygyno_2015_11_029
crossref_primary_10_1007_s10689_017_0047_1
crossref_primary_10_3390_biology10070566
crossref_primary_10_1016_S1773_035X_06_80042_0
crossref_primary_10_1016_j_gyobfe_2009_02_013
crossref_primary_10_1093_jnci_djq494
crossref_primary_10_3389_fonc_2022_976959
crossref_primary_10_1007_s10549_006_9370_1
crossref_primary_10_1007_s00595_011_4503_5
crossref_primary_10_1186_s13053_016_0049_2
crossref_primary_10_1007_s11845_013_0990_2
crossref_primary_10_1007_s10897_009_9228_x
crossref_primary_10_1177_1758834017714993
crossref_primary_10_3802_jgo_2020_31_e24
crossref_primary_10_1016_j_gde_2010_03_001
crossref_primary_10_1016_j_ygyno_2019_03_004
crossref_primary_10_1002_sim_2811
crossref_primary_10_1186_s12885_016_2962_1
crossref_primary_10_18632_oncotarget_6834
crossref_primary_10_1007_s10549_005_9051_5
crossref_primary_10_1097_01_sap_0000205236_88313_10
crossref_primary_10_1016_j_critrevonc_2014_01_008
crossref_primary_10_1097_CAD_0b013e3283627a0b
crossref_primary_10_1111_his_12028
crossref_primary_10_1158_1055_9965_EPI_10_0437
crossref_primary_10_3390_cancers12123645
crossref_primary_10_1186_s13010_018_0069_9
crossref_primary_10_1007_s10549_013_2605_z
crossref_primary_10_1007_s10897_014_9796_2
crossref_primary_10_1007_s10549_012_1958_z
crossref_primary_10_1136_jmedgenet_2018_105599
crossref_primary_10_1007_s00761_006_1139_y
crossref_primary_10_3390_cancers12113479
crossref_primary_10_1007_s10549_024_07476_7
crossref_primary_10_1016_j_ygyno_2021_12_013
crossref_primary_10_2217_pme_15_36
crossref_primary_10_1038_s41588_024_01691_0
crossref_primary_10_1080_0284186X_2017_1404635
crossref_primary_10_1111_j_1600_0412_2011_01121_x
crossref_primary_10_1038_sj_bjc_6603306
crossref_primary_10_1371_journal_pgen_1004256
crossref_primary_10_1186_s12967_015_0698_3
crossref_primary_10_5937_pirotzbor1843115K
crossref_primary_10_1016_j_ygyno_2015_11_001
crossref_primary_10_1080_13816810701649617
crossref_primary_10_1186_bcr971
crossref_primary_10_1093_jnci_djp181
crossref_primary_10_2196_resprot_8138
crossref_primary_10_3389_fonc_2018_00016
crossref_primary_10_3390_pharmaceutics15071839
crossref_primary_10_3389_fmolb_2020_00169
crossref_primary_10_1002_hed_25728
crossref_primary_10_1371_journal_pone_0021639
crossref_primary_10_1007_s00266_021_02506_x
crossref_primary_10_1158_1055_9965_EPI_14_0884
crossref_primary_10_1007_s10549_012_2317_9
crossref_primary_10_1007_s10689_008_9187_7
crossref_primary_10_2217_WHE_15_4
crossref_primary_10_1136_ijgc_00009577_200602001_00009
crossref_primary_10_1371_journal_pone_0030748
crossref_primary_10_1186_bcr1670
crossref_primary_10_1016_j_juro_2012_09_117
crossref_primary_10_1038_s41698_023_00346_3
crossref_primary_10_1093_jnci_djq443
crossref_primary_10_1371_journal_pone_0186043
crossref_primary_10_1016_j_ejso_2006_03_042
crossref_primary_10_3919_jjsa_81_1059
crossref_primary_10_1007_s42764_021_00043_0
crossref_primary_10_1007_s13187_017_1233_4
crossref_primary_10_1038_sj_bjc_6603725
crossref_primary_10_3892_or_2013_2802
crossref_primary_10_1136_ijgc_00009577_200602001_00014
crossref_primary_10_1007_s10549_020_05875_0
crossref_primary_10_1371_journal_pone_0232800
crossref_primary_10_1007_BF03059722
crossref_primary_10_18632_oncotarget_13417
crossref_primary_10_1007_s00280_018_3532_9
crossref_primary_10_1158_2159_8290_CD_12_0421
crossref_primary_10_1186_s12885_019_5595_3
crossref_primary_10_1186_bcr1668
crossref_primary_10_1016_S1550_8579_07_80044_1
crossref_primary_10_1089_lgbt_2017_0148
crossref_primary_10_1089_lgbt_2017_0149
crossref_primary_10_1007_s12038_009_0048_9
crossref_primary_10_1016_j_ctarc_2018_04_001
crossref_primary_10_1016_j_ebiom_2015_09_017
crossref_primary_10_1016_j_ygyno_2009_12_023
crossref_primary_10_1016_S1701_2163_16_34430_9
crossref_primary_10_1097_HP_0b013e318265a257
crossref_primary_10_1093_hmg_ddp372
crossref_primary_10_1111_j_1524_4741_2007_00422_x
crossref_primary_10_1155_2014_459452
crossref_primary_10_1038_nrc_2017_116
crossref_primary_10_23736_S2723_9284_23_00259_0
crossref_primary_10_1080_01443615_2019_1581747
crossref_primary_10_1158_1055_9965_EPI_10_1336
crossref_primary_10_1200_PO_21_00152
crossref_primary_10_3390_cancers13133251
crossref_primary_10_2217_14796694_2_2_257
crossref_primary_10_1016_j_ygyno_2005_08_038
crossref_primary_10_1080_14737140_2018_1510323
crossref_primary_10_1007_s10689_006_9106_8
crossref_primary_10_1093_nar_gkr1227
crossref_primary_10_1002_pon_5166
crossref_primary_10_1016_j_gde_2010_03_010
crossref_primary_10_3390_ijerph19074314
crossref_primary_10_3390_medicina59020300
crossref_primary_10_1177_153303461000900201
crossref_primary_10_1007_s12282_017_0813_9
crossref_primary_10_1016_S0304_5412_13_70526_2
crossref_primary_10_1038_s41523_020_0163_1
crossref_primary_10_5734_JGM_2011_8_2_105
crossref_primary_10_1038_sj_onc_1207714
crossref_primary_10_3892_ol_2023_14012
crossref_primary_10_1186_s12864_024_10311_4
crossref_primary_10_4103_ijmr_IJMR_1868_19
crossref_primary_10_1016_j_breast_2021_07_010
crossref_primary_10_1002_hast_1016
crossref_primary_10_18632_oncotarget_11259
crossref_primary_10_1007_s10549_018_4726_x
crossref_primary_10_3390_ijms21031128
crossref_primary_10_1148_rg_27si075503
crossref_primary_10_4103_ijc_IJC_458_19
crossref_primary_10_1016_j_ejca_2006_07_019
crossref_primary_10_1016_j_clon_2010_11_007
crossref_primary_10_1186_s13053_018_0086_0
crossref_primary_10_1177_107327481602300407
crossref_primary_10_1038_ng2075
crossref_primary_10_1093_annonc_mdt068
crossref_primary_10_1259_bjr_20180032
crossref_primary_10_1016_j_ctarc_2019_100125
crossref_primary_10_1007_s00117_008_1638_5
crossref_primary_10_1074_jbc_M109_088922
crossref_primary_10_1002_cncr_22202
crossref_primary_10_1111_cge_12216
crossref_primary_10_1097_AOG_0b013e3182783c2f
crossref_primary_10_1093_jnci_dji128
crossref_primary_10_3390_cancers16233910
crossref_primary_10_1007_s10897_007_9125_0
crossref_primary_10_1038_s10038_020_0729_7
crossref_primary_10_1200_JCO_2007_13_2779
crossref_primary_10_2214_AJR_13_12146
crossref_primary_10_3390_cancers16010103
crossref_primary_10_3390_genes10030186
crossref_primary_10_1097_SAP_0b013e3181a2c6bd
crossref_primary_10_1093_jnci_djj465
crossref_primary_10_3390_cancers13225594
crossref_primary_10_1038_mp_2017_32
crossref_primary_10_17816_mechnikov112620
crossref_primary_10_1016_j_mric_2006_07_003
crossref_primary_10_3390_cancers11060838
crossref_primary_10_1002_cncr_21367
crossref_primary_10_1634_theoncologist_2016_0444
crossref_primary_10_1016_j_breast_2017_09_007
crossref_primary_10_1200_JCO_2011_37_8133
crossref_primary_10_1080_00313020801911553
crossref_primary_10_1002_pon_1311
crossref_primary_10_1158_1055_9965_EPI_11_1196
crossref_primary_10_17816_clinpract18964
crossref_primary_10_1007_s10911_021_09495_2
crossref_primary_10_1146_annurev_genom_5_061903_180029
crossref_primary_10_1245_s10434_019_07549_8
crossref_primary_10_1245_s10434_014_4108_5
crossref_primary_10_1007_s10689_012_9557_z
crossref_primary_10_1158_1055_9965_EPI_04_0776
crossref_primary_10_18229_kocatepetip_991496
crossref_primary_10_1007_s10897_016_0049_4
crossref_primary_10_1200_JCO_2013_49_3007
crossref_primary_10_1016_j_ygyno_2017_02_032
crossref_primary_10_1158_0008_5472_CAN_09_0625
crossref_primary_10_1007_s10549_013_2669_9
crossref_primary_10_1051_medsci_2019072
crossref_primary_10_1089_gtmb_2010_0098
crossref_primary_10_3390_ijms24097839
crossref_primary_10_1093_annonc_mdi041
crossref_primary_10_1007_s10549_010_0799_x
crossref_primary_10_1093_jnci_djv315
crossref_primary_10_1186_bcr1293
crossref_primary_10_1186_s12958_019_0561_0
crossref_primary_10_1111_1471_0528_15153
crossref_primary_10_1016_j_ejso_2019_09_002
crossref_primary_10_1007_s10549_011_1423_4
crossref_primary_10_21518_2079_701X_2022_16_9_179_184
crossref_primary_10_1158_1078_0432_CCR_07_4806
crossref_primary_10_7314_APJCP_2015_16_6_2177
crossref_primary_10_1016_j_ygyno_2019_05_017
crossref_primary_10_1007_s00268_010_0477_5
crossref_primary_10_1007_s10549_016_3792_1
crossref_primary_10_1016_j_pec_2014_07_004
crossref_primary_10_1007_s11033_021_06243_x
crossref_primary_10_1158_1940_6207_CAPR_15_0408
crossref_primary_10_1007_s11427_019_9526_2
crossref_primary_10_1016_j_mrrev_2007_07_001
crossref_primary_10_1002_humu_22678
crossref_primary_10_21931_RB_2022_07_01_20
crossref_primary_10_1016_j_bpobgyn_2009_08_002
crossref_primary_10_1148_radiol_11110352
crossref_primary_10_1186_s12942_016_0076_2
crossref_primary_10_1002_cncr_21393
crossref_primary_10_4236_abcr_2013_23010
crossref_primary_10_1007_s10549_006_9417_3
crossref_primary_10_1158_1055_9965_EPI_06_0176
crossref_primary_10_1016_j_fertnstert_2013_03_020
crossref_primary_10_5301_ijbm_5000290
crossref_primary_10_1158_1055_9965_EPI_06_0178
crossref_primary_10_1111_1471_0528_16424
crossref_primary_10_1038_bjc_2013_70
crossref_primary_10_3390_genes13081296
crossref_primary_10_1007_s10549_015_3629_3
crossref_primary_10_1093_annonc_mdv298
crossref_primary_10_1016_S0140_6736_13_62146_7
crossref_primary_10_18632_aging_202870
crossref_primary_10_1016_j_ijpp_2018_03_002
crossref_primary_10_1089_jwh_2009_1622
crossref_primary_10_1080_14737159_2019_1657011
crossref_primary_10_1016_S1470_2045_11_70222_4
crossref_primary_10_1038_sj_bjc_6602239
crossref_primary_10_1016_j_gene_2018_10_044
crossref_primary_10_1158_0008_5472_CAN_10_1907
crossref_primary_10_1016_j_gofs_2017_01_008
crossref_primary_10_3390_jcm12041422
crossref_primary_10_1007_s00104_008_1556_0
crossref_primary_10_1038_sj_onc_1208985
crossref_primary_10_1016_j_breast_2021_04_011
crossref_primary_10_1111_j_1525_1438_2006_00481_x
crossref_primary_10_1051_medsci_2019003
crossref_primary_10_1158_1055_9965_EPI_14_6_ED
crossref_primary_10_1016_j_acpath_2023_100091
crossref_primary_10_3892_etm_2011_337
crossref_primary_10_1007_s10689_012_9531_9
crossref_primary_10_5306_wjco_v5_i3_495
crossref_primary_10_1016_j_ygyno_2017_10_034
crossref_primary_10_17116_repro20202604159
crossref_primary_10_1093_hmg_ddaa087
crossref_primary_10_1007_s10897_008_9150_7
crossref_primary_10_1186_1471_2407_12_531
crossref_primary_10_1016_j_clon_2015_06_001
crossref_primary_10_1007_s13691_021_00481_3
crossref_primary_10_1002_jso_21856
crossref_primary_10_1007_s10897_017_0194_4
crossref_primary_10_1093_jpepsy_jsr040
crossref_primary_10_1517_17530059_2012_702105
crossref_primary_10_1186_s12909_021_02774_w
crossref_primary_10_20960_revmedlab_00024
crossref_primary_10_1007_s10552_014_0521_0
crossref_primary_10_1016_j_maturitas_2015_06_008
crossref_primary_10_1053_j_seminoncol_2007_07_004
crossref_primary_10_2217_fon_10_191
crossref_primary_10_1007_s10689_012_9588_5
crossref_primary_10_1053_j_seminoncol_2007_07_006
crossref_primary_10_1186_s12885_020_6688_8
crossref_primary_10_1186_2193_1801_3_264
crossref_primary_10_1177_107327481201900402
crossref_primary_10_1111_j_1447_0756_2009_01090_x
crossref_primary_10_1200_JCO_2007_11_1179
crossref_primary_10_3390_cancers15235699
crossref_primary_10_1186_1897_4287_11_12
crossref_primary_10_3389_fgene_2022_982930
crossref_primary_10_3390_nu13041208
crossref_primary_10_1186_1897_4287_11_10
crossref_primary_10_1002_jcb_26515
crossref_primary_10_1097_01_AOG_0000466373_71146_51
crossref_primary_10_1053_j_seminoncol_2016_10_001
crossref_primary_10_1186_1471_2407_13_339
crossref_primary_10_1055_s_0042_1760325
crossref_primary_10_1039_C7NR05250B
crossref_primary_10_1007_s10549_017_4642_5
crossref_primary_10_1038_s41568_023_00599_x
crossref_primary_10_1097_PPO_0000000000000596
crossref_primary_10_1111_j_1399_0004_2007_00866_x
crossref_primary_10_1007_s12282_016_0673_8
crossref_primary_10_1007_s10549_014_2842_9
crossref_primary_10_1186_1471_2407_9_236
crossref_primary_10_1016_j_ejso_2009_03_006
crossref_primary_10_1097_MD_0000000000004975
crossref_primary_10_1002_pon_3560
crossref_primary_10_1038_s41598_017_18436_1
crossref_primary_10_1097_PRS_0000000000004363
crossref_primary_10_1016_j_femme_2011_02_003
crossref_primary_10_26442_18151434_2024_1_202656
crossref_primary_10_1038_sj_onc_1209879
crossref_primary_10_1007_s10916_010_9603_z
crossref_primary_10_1186_s13104_016_2057_8
crossref_primary_10_1515_hmbci_2019_0065
crossref_primary_10_1002_path_1774
crossref_primary_10_1186_1477_7827_1_70
crossref_primary_10_1002_ijc_20429
crossref_primary_10_1016_j_ygyno_2017_07_141
crossref_primary_10_1007_s10689_014_9708_5
crossref_primary_10_1038_s41416_019_0492_8
crossref_primary_10_1684_bdc_2011_1397
crossref_primary_10_1038_sj_onc_1209876
crossref_primary_10_1177_0306312705048716
crossref_primary_10_1007_s11739_010_0455_9
crossref_primary_10_1186_1472_6874_11_39
crossref_primary_10_1016_j_rcl_2020_09_004
crossref_primary_10_1371_journal_pdig_0000589
crossref_primary_10_1016_j_rcl_2020_09_006
crossref_primary_10_1038_sj_onc_1209870
crossref_primary_10_1016_j_maturitas_2008_03_004
crossref_primary_10_1016_j_canep_2010_06_007
crossref_primary_10_1093_tbm_ibab093
crossref_primary_10_1016_j_critrevonc_2012_10_004
crossref_primary_10_1051_medsci_200521126
crossref_primary_10_1155_2022_9623173
crossref_primary_10_1177_1049731515615678
crossref_primary_10_1007_s10549_004_2172_4
crossref_primary_10_3389_fonc_2020_531790
crossref_primary_10_1097_IGC_0000000000000134
crossref_primary_10_1097_MCG_0000000000001683
crossref_primary_10_1158_1055_9965_EPI_04_0376
crossref_primary_10_1186_s12913_021_07449_2
crossref_primary_10_1007_s10549_014_2864_3
crossref_primary_10_1016_j_clon_2018_04_004
crossref_primary_10_1016_j_bbadis_2017_10_015
crossref_primary_10_3390_diagnostics7020022
crossref_primary_10_1158_1055_9965_EPI_05_0986
crossref_primary_10_1007_s10689_016_9878_4
crossref_primary_10_13005_bbra_2651
crossref_primary_10_1007_s12282_020_01148_2
crossref_primary_10_3390_cancers10120506
crossref_primary_10_1038_sj_onc_1209881
crossref_primary_10_1186_s13058_024_01957_9
crossref_primary_10_1016_j_mgene_2017_11_002
crossref_primary_10_1007_s10147_021_02087_4
crossref_primary_10_1016_j_ygyno_2017_10_001
crossref_primary_10_1089_gtmb_2012_0381
crossref_primary_10_1016_j_cancergen_2012_04_002
crossref_primary_10_1038_ejhg_2014_16
crossref_primary_10_1093_jnci_djn442
crossref_primary_10_1007_s10689_012_9540_8
crossref_primary_10_1002_ajmg_c_30163
crossref_primary_10_1007_s10552_008_9175_0
crossref_primary_10_1038_onc_2011_55
crossref_primary_10_1049_iet_syb_2016_0016
crossref_primary_10_1080_14733400500233652
crossref_primary_10_4048_jbc_2024_0219
crossref_primary_10_1002_humu_20894
crossref_primary_10_1186_s13053_019_0117_5
crossref_primary_10_1093_jnci_djn440
crossref_primary_10_1002_humu_20415
crossref_primary_10_1016_j_breastdis_2015_07_038
crossref_primary_10_1186_s12885_020_07128_1
crossref_primary_10_24911_JBCGenetics_183_1606168933
crossref_primary_10_1038_sj_onc_1207249
crossref_primary_10_1093_jnci_djj012
crossref_primary_10_1016_j_ejca_2013_04_028
crossref_primary_10_1093_annonc_mdn724
crossref_primary_10_1200_JCO_2005_08_096
crossref_primary_10_3109_02841860903521095
crossref_primary_10_1007_s10549_012_2159_5
crossref_primary_10_1186_s12920_019_0545_0
crossref_primary_10_1002_cncr_28879
crossref_primary_10_1038_s41523_017_0052_4
crossref_primary_10_1186_bcr3052
crossref_primary_10_1016_j_pop_2014_02_012
crossref_primary_10_3390_cancers10120524
crossref_primary_10_4065_mcp_2010_0414
crossref_primary_10_1038_s41576_020_0224_1
crossref_primary_10_1093_jncics_pkz075
crossref_primary_10_1007_s00216_022_04388_7
crossref_primary_10_1089_gte_2006_9998
crossref_primary_10_1136_jmedgenet_2013_101974
crossref_primary_10_1097_PPO_0b013e3181cf0204
crossref_primary_10_1089_gtmb_2010_0027
crossref_primary_10_1093_humrep_dew044
crossref_primary_10_3390_diagnostics7020024
crossref_primary_10_1056_NEJMoa1400382
crossref_primary_10_1016_j_breast_2015_02_001
crossref_primary_10_1002_mc_23829
crossref_primary_10_3343_alm_2020_40_2_114
crossref_primary_10_1186_1897_4287_9_10
crossref_primary_10_1016_S2666_7568_21_00280_4
crossref_primary_10_1038_s41467_017_01180_5
crossref_primary_10_3390_cancers10120513
crossref_primary_10_1093_nar_gkab151
crossref_primary_10_1186_1897_4287_9_11
crossref_primary_10_3322_caac_21408
crossref_primary_10_2217_fon_14_82
crossref_primary_10_1080_14737159_2023_2173579
crossref_primary_10_1111_jog_15326
crossref_primary_10_1007_s10549_011_1917_0
crossref_primary_10_1038_nrclinonc_2010_175
crossref_primary_10_1016_j_ygyno_2006_11_015
crossref_primary_10_1038_ejhg_2014_40
crossref_primary_10_1016_j_clbc_2017_02_004
crossref_primary_10_1016_j_gofs_2023_03_001
crossref_primary_10_1002_14651858_CD003721_pub3
crossref_primary_10_1016_j_jgyn_2014_10_011
crossref_primary_10_1111_j_1399_0004_2009_01328_x
crossref_primary_10_1016_j_acra_2020_03_039
crossref_primary_10_1038_bjc_2016_311
crossref_primary_10_1186_s12885_019_5908_6
crossref_primary_10_1200_JCO_2008_21_7588
crossref_primary_10_1158_1055_9965_EPI_13_0980
crossref_primary_10_1002_pd_2232
crossref_primary_10_1016_j_ygyno_2011_10_027
crossref_primary_10_1002_cncr_29707
crossref_primary_10_1038_nrclinonc_2010_166
crossref_primary_10_1002_cncr_29708
crossref_primary_10_1016_j_mcna_2015_01_002
crossref_primary_10_1007_s10552_012_0127_3
crossref_primary_10_1007_s10689_012_9584_9
crossref_primary_10_4155_fmc_11_175
crossref_primary_10_1158_1055_9965_EPI_10_0909
crossref_primary_10_1038_jhg_2017_50
crossref_primary_10_3390_healthcare9091145
crossref_primary_10_1016_j_gyobfe_2009_12_014
crossref_primary_10_1007_s10549_020_05949_z
crossref_primary_10_1186_bcr2172
crossref_primary_10_1016_j_breast_2021_02_001
crossref_primary_10_1016_j_ygyno_2018_07_024
crossref_primary_10_1073_pnas_0511301103
crossref_primary_10_1111_bjd_13626
crossref_primary_10_5301_JBM_2012_10370
crossref_primary_10_1007_s10549_006_9349_y
crossref_primary_10_1158_0008_5472_CAN_08_0599
crossref_primary_10_1097_01_cej_0000220624_70234_14
crossref_primary_10_1038_s10038_022_01065_6
crossref_primary_10_1158_1055_9965_EPI_16_0182
crossref_primary_10_1007_s10897_011_9350_4
crossref_primary_10_1016_j_maturitas_2016_06_012
crossref_primary_10_1159_000505226
crossref_primary_10_1186_s13058_019_1132_1
crossref_primary_10_1016_S0001_4079_19_31707_8
crossref_primary_10_4103_CRST_CRST_101_19
crossref_primary_10_1016_j_canlet_2006_08_012
crossref_primary_10_1097_01_pas_0000202161_80739_ac
crossref_primary_10_1111_cas_13824
crossref_primary_10_3390_cancers10090277
crossref_primary_10_1007_s11864_012_0215_3
crossref_primary_10_1016_j_jpsychires_2020_11_023
crossref_primary_10_1007_s00129_011_2857_9
crossref_primary_10_1016_j_ajhg_2008_02_008
crossref_primary_10_1016_j_ejrad_2017_10_003
crossref_primary_10_1056_NEJMra0802968
crossref_primary_10_3390_ijms21030768
crossref_primary_10_3892_mmr_2014_2221
crossref_primary_10_1007_s10689_013_9685_0
crossref_primary_10_1186_bcr1750
crossref_primary_10_1158_1055_9965_EPI_11_0797
crossref_primary_10_26508_lsa_202302342
crossref_primary_10_1002_ccr3_70043
crossref_primary_10_1016_j_bbcan_2020_188459
crossref_primary_10_1158_1055_9965_2258_13_12
crossref_primary_10_1038_bjc_2012_204
crossref_primary_10_1007_s13277_014_2718_y
crossref_primary_10_1053_j_seminoncol_2011_04_008
crossref_primary_10_1007_s10897_013_9663_6
crossref_primary_10_1002_cncr_30621
crossref_primary_10_1007_s10815_014_0355_4
crossref_primary_10_1016_j_suronc_2019_04_009
crossref_primary_10_1055_a_1222_0042
crossref_primary_10_1007_s10549_008_0083_5
crossref_primary_10_1638_2015_0303_1
crossref_primary_10_1111_j_1399_0004_2007_00742_x
crossref_primary_10_1371_journal_pone_0004812
crossref_primary_10_1371_journal_pone_0056379
crossref_primary_10_2217_fon_2023_0665
crossref_primary_10_1016_j_eujim_2016_04_001
crossref_primary_10_1007_s10549_016_3766_3
crossref_primary_10_1080_20905068_2024_2341368
crossref_primary_10_1016_j_ddmec_2004_09_002
crossref_primary_10_1016_j_ajhg_2022_09_006
crossref_primary_10_1038_nrc1321
crossref_primary_10_3389_fcell_2021_760618
crossref_primary_10_1080_03461230601026635
crossref_primary_10_1007_s10549_018_4810_2
crossref_primary_10_1007_BF03351326
crossref_primary_10_1016_j_ijbiomac_2020_06_222
crossref_primary_10_1007_s00761_009_1744_7
crossref_primary_10_1016_j_cct_2018_09_005
crossref_primary_10_3804_jjabcs_27_29
crossref_primary_10_1111_IGC_0b013e3181dbd1a5
crossref_primary_10_1016_j_ccell_2021_02_018
crossref_primary_10_1073_pnas_2108421118
crossref_primary_10_1371_journal_pone_0275015
crossref_primary_10_1155_2013_852839
crossref_primary_10_1007_s10689_009_9269_1
crossref_primary_10_1148_rg_2020190084
crossref_primary_10_3389_fphar_2022_823572
crossref_primary_10_1097_01_AOG_0000295638_83285_97
crossref_primary_10_1007_s10689_010_9338_5
crossref_primary_10_1016_j_cancergencyto_2009_06_019
crossref_primary_10_1056_NEJMc1410673
crossref_primary_10_1007_s00268_011_1406_y
crossref_primary_10_1053_j_gastro_2014_11_042
crossref_primary_10_1210_clinem_dgaa073
crossref_primary_10_2217_pme_12_58
crossref_primary_10_1016_j_trsl_2012_01_022
crossref_primary_10_2174_1573404814666180808105454
crossref_primary_10_1007_s10689_012_9518_6
crossref_primary_10_1097_00002820_200701000_00015
crossref_primary_10_1016_j_ando_2007_12_001
crossref_primary_10_1245_s10434_024_15793_w
crossref_primary_10_1038_s41467_019_13194_2
crossref_primary_10_1186_1757_2215_3_8
crossref_primary_10_1200_JCO_2016_69_9330
crossref_primary_10_1038_s41598_024_77186_z
crossref_primary_10_1038_ejhg_2016_141
crossref_primary_10_20915_2077_1177_2023_19_2_5_17
crossref_primary_10_2478_raon_2020_0020
crossref_primary_10_1007_s10549_014_2980_0
crossref_primary_10_1016_j_humpath_2014_10_020
crossref_primary_10_1002_humu_20845
crossref_primary_10_2217_pgs_15_27
crossref_primary_10_1007_s10549_006_9225_9
crossref_primary_10_1093_annonc_mdl947
crossref_primary_10_1097_PRS_0b013e3182a00e79
crossref_primary_10_1002_gepi_20390
crossref_primary_10_1097_01_AOG_0000228959_30577_13
crossref_primary_10_1158_1055_9965_EPI_08_0065
crossref_primary_10_7759_cureus_37889
crossref_primary_10_1016_j_ejca_2005_03_035
crossref_primary_10_4132_jptm_2024_08_14
crossref_primary_10_1016_j_ijgo_2013_12_001
crossref_primary_10_1002_wrna_1814
crossref_primary_10_1245_s10434_021_10445_9
crossref_primary_10_3390_cancers15123120
crossref_primary_10_1038_s12276_018_0112_3
crossref_primary_10_1111_cge_13191
crossref_primary_10_1016_j_bjps_2008_07_012
crossref_primary_10_1136_ijgc_00009577_200409000_00002
crossref_primary_10_1093_carcin_bgr056
crossref_primary_10_1186_1471_2350_12_9
crossref_primary_10_1007_s10897_011_9376_7
crossref_primary_10_2217_pgs_12_137
crossref_primary_10_1093_jnci_djw290
crossref_primary_10_1158_0008_5472_CAN_05_3546
crossref_primary_10_1016_j_canlet_2003_10_005
crossref_primary_10_1158_1055_9965_EPI_10_0517
crossref_primary_10_1007_s10549_006_9456_9
crossref_primary_10_1038_sj_bjc_6602703
crossref_primary_10_1158_1078_0432_CCR_07_4436
crossref_primary_10_1038_s41467_020_15912_7
crossref_primary_10_3389_fgene_2022_920390
crossref_primary_10_1002_ijc_22261
crossref_primary_10_1093_hmg_ddq174
crossref_primary_10_1097_CMR_0000000000000613
crossref_primary_10_1080_0167482X_2017_1296429
crossref_primary_10_1007_s10689_012_9527_5
crossref_primary_10_1016_j_ygyno_2023_10_023
crossref_primary_10_1093_annonc_mdq365
crossref_primary_10_1016_S1283_081X_16_82412_1
crossref_primary_10_1136_jmedgenet_2015_103452
crossref_primary_10_1002_jcb_26195
crossref_primary_10_1016_j_ejca_2007_06_007
crossref_primary_10_4103_ijmpo_ijmpo_172_19
crossref_primary_10_1002_pon_3039
crossref_primary_10_1182_bloodadvances_2021006654
crossref_primary_10_1016_j_biopha_2022_114090
crossref_primary_10_1002_cncr_22603
crossref_primary_10_1007_s10549_014_3074_8
crossref_primary_10_1684_bdc_2012_1544
crossref_primary_10_1016_j_gofs_2017_12_012
crossref_primary_10_1089_jwh_2013_4259
crossref_primary_10_1080_15513815_2016_1225873
crossref_primary_10_1038_sj_bjc_6605833
crossref_primary_10_1016_j_ygyno_2019_11_019
crossref_primary_10_1016_j_bpobgyn_2011_11_002
crossref_primary_10_1007_s00395_024_01090_w
crossref_primary_10_1038_s41571_020_0327_9
crossref_primary_10_1007_s40291_015_0136_5
crossref_primary_10_1007_s10549_016_4029_z
crossref_primary_10_1016_j_rcl_2016_12_006
crossref_primary_10_1111_cge_12291
crossref_primary_10_1200_PO_21_00450
crossref_primary_10_3390_ijerph16244995
crossref_primary_10_1007_s11912_006_0004_x
crossref_primary_10_1093_jnci_djj500
crossref_primary_10_1200_JCO_2012_45_4678
crossref_primary_10_1016_j_canlet_2019_10_019
crossref_primary_10_17650_2686_9594_2022_12_3_56_62
crossref_primary_10_1007_s11825_015_0044_4
crossref_primary_10_1038_oby_2011_394
crossref_primary_10_2147_OTT_S335139
crossref_primary_10_1007_s10689_015_9790_3
crossref_primary_10_7314_APJCP_2013_14_2_723
crossref_primary_10_1097_01_cej_0000220628_62610_ea
crossref_primary_10_1097_IGC_0b013e31823d1b5c
crossref_primary_10_1186_bcr1348
crossref_primary_10_1089_gtmb_2008_0067
crossref_primary_10_1038_s41588_018_0202_0
crossref_primary_10_1007_s10689_014_9769_5
crossref_primary_10_1007_s10549_020_06070_x
crossref_primary_10_1016_j_cancergen_2015_02_001
crossref_primary_10_1016_j_clbc_2010_11_001
crossref_primary_10_1002_cncr_26191
crossref_primary_10_1097_CEJ_0b013e32832bf421
crossref_primary_10_1200_PO_22_00447
crossref_primary_10_1097_RCT_0000000000001334
crossref_primary_10_1016_j_bpobgyn_2016_10_017
crossref_primary_10_1016_j_maturitas_2013_10_017
crossref_primary_10_1158_0008_5472_CAN_11_0773
crossref_primary_10_1016_j_stemcr_2020_03_004
crossref_primary_10_1177_03000605231223426
crossref_primary_10_1186_s12885_024_12160_6
crossref_primary_10_1371_journal_pone_0058182
crossref_primary_10_1007_s40944_021_00557_1
crossref_primary_10_1002_humu_23017
crossref_primary_10_1007_s10689_011_9435_0
crossref_primary_10_1038_s41598_020_73505_2
crossref_primary_10_1097_GME_0000000000000126
crossref_primary_10_1111_tbj_13970
crossref_primary_10_1111_cge_12270
crossref_primary_10_1684_bdc_2014_1888
crossref_primary_10_3390_ijms151223024
crossref_primary_10_4048_jbc_2010_13_4_418
crossref_primary_10_1097_01_cej_0000203615_77183_97
crossref_primary_10_18553_jmcp_2024_30_9_942
crossref_primary_10_1093_jjco_hyt171
crossref_primary_10_1111_j_1745_7599_2005_00091_x
crossref_primary_10_4236_ojab_2014_32002
crossref_primary_10_1016_j_genrep_2018_07_005
crossref_primary_10_1093_ije_dyy039
crossref_primary_10_1200_JCO_2006_06_8148
crossref_primary_10_1016_j_ajhg_2012_01_007
crossref_primary_10_1016_j_currproblcancer_2013_10_009
crossref_primary_10_1016_j_ogc_2005_08_010
crossref_primary_10_1002_mgg3_191
crossref_primary_10_1002_humu_22159
crossref_primary_10_1007_s10549_010_0805_3
crossref_primary_10_1016_j_ajog_2017_04_011
crossref_primary_10_1186_1471_2407_11_265
crossref_primary_10_3919_jjsa_80_499
crossref_primary_10_1038_sj_ejhg_5201511
crossref_primary_10_1038_s41431_023_01297_w
crossref_primary_10_1515_CCLM_2008_307
crossref_primary_10_3390_ijms23031205
crossref_primary_10_1146_annurev_pathol_3_121806_151422
crossref_primary_10_1002_jgc4_1051
crossref_primary_10_1053_j_gastro_2011_02_071
crossref_primary_10_1007_s12282_014_0555_x
crossref_primary_10_1007_s10549_023_07234_1
crossref_primary_10_1038_s41416_023_02263_5
crossref_primary_10_1016_j_atherosclerosis_2015_10_104
crossref_primary_10_1016_j_mric_2010_02_003
crossref_primary_10_1016_S1470_2045_11_70214_5
crossref_primary_10_1101_sqb_2005_70_029
crossref_primary_10_1097_AOG_0b013e31821c62b6
crossref_primary_10_29169_1927_5951_2020_10_04_5
crossref_primary_10_1007_s10549_015_3495_z
crossref_primary_10_1016_j_ygyno_2011_12_415
crossref_primary_10_1007_s10689_004_9552_0
crossref_primary_10_1186_bcr2647
crossref_primary_10_1186_s13058_024_01769_x
crossref_primary_10_21294_1814_4861_2022_21_6_145_155
crossref_primary_10_1200_JCO_2007_11_0262
crossref_primary_10_1097_01720610_200805000_00008
crossref_primary_10_1002_jcp_27464
crossref_primary_10_1186_1897_4287_8_2
crossref_primary_10_1186_bcr632
crossref_primary_10_1007_s10549_015_3393_4
crossref_primary_10_1007_s10549_012_2009_5
crossref_primary_10_1007_s10549_009_0486_y
crossref_primary_10_1007_s10549_020_05985_9
crossref_primary_10_1186_s12885_015_1516_2
crossref_primary_10_1200_JCO_19_01907
crossref_primary_10_1002_dc_21589
crossref_primary_10_1016_j_ygyno_2021_07_034
crossref_primary_10_1002_dc_21129
crossref_primary_10_1586_era_09_38
crossref_primary_10_1016_j_ygyno_2005_07_110
crossref_primary_10_1002_pon_925
crossref_primary_10_1016_j_cnur_2009_06_004
crossref_primary_10_1002_gepi_21620
crossref_primary_10_1016_S1359_6349_04_90599_X
crossref_primary_10_1016_S0221_0363_08_73784_3
crossref_primary_10_1007_s00439_004_1206_7
crossref_primary_10_1007_s43032_024_01666_w
crossref_primary_10_1007_s10549_015_3429_9
crossref_primary_10_1007_s11154_007_9038_0
crossref_primary_10_1158_1055_9965_EPI_21_1196
crossref_primary_10_3389_fonc_2021_674965
crossref_primary_10_1111_cge_12233
crossref_primary_10_1007_s12609_009_0020_6
crossref_primary_10_1186_s13053_024_00285_5
crossref_primary_10_15369_sujms_26_219
crossref_primary_10_1007_s00439_018_1938_4
crossref_primary_10_1089_109065704323015987
crossref_primary_10_1007_s40883_019_00141_2
crossref_primary_10_1097_PRS_0b013e318177415e
crossref_primary_10_1186_1897_4287_10_4
crossref_primary_10_5858_arpa_2018_0289_RA
crossref_primary_10_1097_IGC_0000000000000964
crossref_primary_10_3389_fonc_2022_821366
crossref_primary_10_1016_j_ejca_2004_10_029
crossref_primary_10_3390_healthcare5020026
crossref_primary_10_1097_CEJ_0000000000000606
crossref_primary_10_1158_1078_0432_CCR_08_0210
crossref_primary_10_3389_fonc_2021_700853
crossref_primary_10_1017_S174849950000018X
crossref_primary_10_3390_ijms24010764
crossref_primary_10_1007_s10897_018_0264_2
crossref_primary_10_1177_10781552221080081
crossref_primary_10_1002_ijc_32903
crossref_primary_10_1007_s10897_007_9112_5
crossref_primary_10_1007_s10689_011_9422_5
crossref_primary_10_2174_1875692119666220225140848
crossref_primary_10_1038_nrendo_2016_50
crossref_primary_10_1016_j_soc_2015_06_011
crossref_primary_10_1245_s10434_007_9612_4
crossref_primary_10_1002_pbc_25303
crossref_primary_10_1016_j_rcl_2016_12_013
crossref_primary_10_1016_j_breast_2016_08_016
crossref_primary_10_1007_s10549_009_0475_1
crossref_primary_10_1007_s10689_012_9512_z
crossref_primary_10_2214_AJR_13_12264
crossref_primary_10_1007_s10689_008_9181_0
crossref_primary_10_14730_aaps_2023_01067
crossref_primary_10_1186_s12885_017_3631_8
crossref_primary_10_1038_sj_bjc_6603015
crossref_primary_10_1016_j_soncn_2018_12_001
crossref_primary_10_1007_s10689_015_9783_2
crossref_primary_10_1158_1055_9965_EPI_08_0546
crossref_primary_10_1158_1055_9965_733_13_5
crossref_primary_10_1186_1471_2407_13_243
crossref_primary_10_1007_s00404_010_1476_3
crossref_primary_10_1136_jcp_2008_062646
crossref_primary_10_1016_j_clbc_2012_05_002
crossref_primary_10_1021_acsomega_3c03867
crossref_primary_10_7759_cureus_55712
crossref_primary_10_1016_j_pop_2004_05_001
crossref_primary_10_3390_jpm12091467
crossref_primary_10_1007_s10549_013_2722_8
crossref_primary_10_1016_j_ejso_2008_03_002
crossref_primary_10_1016_j_gore_2022_100948
crossref_primary_10_1056_NEJMsr1501341
crossref_primary_10_1093_jalm_jfab163
crossref_primary_10_1155_2020_3289023
crossref_primary_10_1038_nature05887
crossref_primary_10_1007_s10689_020_00179_0
crossref_primary_10_1007_s10549_019_05199_8
crossref_primary_10_1007_s10549_011_1655_3
crossref_primary_10_1111_j_1524_4741_2011_01133_x
crossref_primary_10_1007_s11839_015_0549_8
crossref_primary_10_1016_j_ajpath_2013_07_003
crossref_primary_10_1056_NEJMc1602861
crossref_primary_10_1080_02841860802343182
crossref_primary_10_1002_jso_24193
crossref_primary_10_1038_s41598_022_06376_4
crossref_primary_10_4061_2011_481563
crossref_primary_10_1007_s10689_009_9305_1
crossref_primary_10_1186_bcr3121
crossref_primary_10_1371_journal_pgen_1000080
crossref_primary_10_1016_j_ygeno_2010_03_003
crossref_primary_10_1038_ng_3934
crossref_primary_10_1177_1609406917750973
crossref_primary_10_3390_cancers12030710
crossref_primary_10_1371_journal_pone_0163193
crossref_primary_10_1016_j_suc_2013_01_005
crossref_primary_10_1097_GME_0000000000001176
crossref_primary_10_1002_jcla_22418
crossref_primary_10_1158_1078_0432_CCR_13_0066
crossref_primary_10_1186_1471_2407_13_46
crossref_primary_10_3390_medicina55080482
crossref_primary_10_1007_s10549_014_2943_5
crossref_primary_10_1111_jcmm_12504
crossref_primary_10_1007_s10549_009_0595_7
crossref_primary_10_1016_S0140_6736_05_67601_5
crossref_primary_10_1007_s40291_015_0168_x
crossref_primary_10_1053_j_seminoncol_2009_03_001
crossref_primary_10_1111_j_1751_9861_2008_00028_x
crossref_primary_10_1186_1471_2407_12_454
crossref_primary_10_18632_oncotarget_22191
crossref_primary_10_1158_1055_9965_EPI_13_0426
crossref_primary_10_1186_bcr3591
crossref_primary_10_1007_s10689_006_0006_8
crossref_primary_10_1007_s10689_011_9477_3
crossref_primary_10_1093_bmb_ldu034
crossref_primary_10_1155_2014_542541
crossref_primary_10_1158_1055_9965_EPI_05_0223
crossref_primary_10_1001_jamanetworkopen_2022_22092
crossref_primary_10_1089_gte_2004_8_235
crossref_primary_10_1371_journal_pone_0074013
crossref_primary_10_1007_s10897_005_1371_4
crossref_primary_10_1097_IGC_0000000000000403
crossref_primary_10_1038_sj_bjc_6602175
crossref_primary_10_1200_JCO_2004_00_7138
crossref_primary_10_5734_JGM_2013_10_2_124
crossref_primary_10_1016_j_bpobgyn_2017_01_004
crossref_primary_10_17650_2782_3202_2023_3_4_28_34
crossref_primary_10_3390_cancers17050787
crossref_primary_10_1093_jncics_pkab044
crossref_primary_10_1111_jcmm_12995
crossref_primary_10_1002_mgg3_464
crossref_primary_10_1155_2023_9961341
crossref_primary_10_1111_cge_12563
crossref_primary_10_1186_s12889_020_09267_3
crossref_primary_10_1016_j_ygyno_2006_08_004
crossref_primary_10_3390_cancers14215278
crossref_primary_10_1038_bjc_2012_31
crossref_primary_10_3389_fonc_2020_568786
crossref_primary_10_1002_pros_23795
crossref_primary_10_1080_17460441_2017_1322061
crossref_primary_10_1080_01635580701458160
crossref_primary_10_1007_s10549_015_3596_8
crossref_primary_10_1186_s12885_024_13408_x
crossref_primary_10_1148_radiol_09091086
crossref_primary_10_1002_ajmg_c_30019
crossref_primary_10_1007_s12094_018_02007_5
crossref_primary_10_1016_j_ygyno_2018_10_014
crossref_primary_10_1007_s10689_020_00166_5
crossref_primary_10_1016_j_ebiom_2021_103446
crossref_primary_10_1038_sj_bjc_6604305
crossref_primary_10_1136_jmedgenet_2017_104560
crossref_primary_10_3934_genet_2015_4_281
crossref_primary_10_1155_2022_1734049
crossref_primary_10_4161_cbt_20559
crossref_primary_10_5694_mja13_10848
crossref_primary_10_1158_1055_9965_EPI_05_0687
crossref_primary_10_1177_1049732314528756
crossref_primary_10_1016_j_rigapp_2006_05_009
crossref_primary_10_1158_1055_9965_EPI_09_0359
crossref_primary_10_4103_bbrj_bbrj_206_21
crossref_primary_10_1200_JCO_2005_01_9737
crossref_primary_10_1007_s10689_016_9875_7
crossref_primary_10_1038_nm_4118
crossref_primary_10_1056_NEJMcp071286
crossref_primary_10_1007_s00439_008_0529_1
crossref_primary_10_1111_1567_1364_12094
crossref_primary_10_1136_jcp_2009_065169
crossref_primary_10_1007_s10552_015_0601_9
crossref_primary_10_1016_j_breast_2014_12_003
crossref_primary_10_1007_s10549_015_3374_7
crossref_primary_10_1007_s10549_011_1886_3
crossref_primary_10_18632_oncotarget_24382
crossref_primary_10_1200_JGO_19_00170
crossref_primary_10_1038_s10038_023_01140_6
crossref_primary_10_1016_j_maturitas_2014_05_002
crossref_primary_10_1016_j_gendis_2022_07_004
crossref_primary_10_1186_bcr1387
crossref_primary_10_1576_toag_7_1_023_27038
crossref_primary_10_1016_j_bbcan_2023_188907
crossref_primary_10_18632_oncotarget_16791
crossref_primary_10_1007_s10549_007_9848_5
crossref_primary_10_1002_pon_1879
crossref_primary_10_1002_em_21729
crossref_primary_10_1007_s12609_014_0156_x
crossref_primary_10_1159_000502889
crossref_primary_10_3389_pore_2022_1610377
crossref_primary_10_1007_s10549_018_4903_y
crossref_primary_10_1002_cncr_31069
crossref_primary_10_3390_cancers10110453
crossref_primary_10_1007_s10689_007_9178_0
crossref_primary_10_1158_0008_5472_CAN_11_3834
crossref_primary_10_1007_s10549_010_1336_7
crossref_primary_10_1016_j_crad_2007_07_029
crossref_primary_10_1152_physiolgenomics_00033_2023
crossref_primary_10_1086_522611
crossref_primary_10_1089_gtmb_2009_0183
crossref_primary_10_1002_jgc4_1568
crossref_primary_10_1007_s10689_017_0050_6
crossref_primary_10_1017_S0266462319003519
crossref_primary_10_1177_1457496913490460
crossref_primary_10_1097_AOG_0000000000004364
crossref_primary_10_1002_humu_21269
crossref_primary_10_1097_01_AOG_0000180181_68069_99
crossref_primary_10_1007_s10549_020_05922_w
crossref_primary_10_1111_j_1525_1438_2006_00480_x
crossref_primary_10_1186_bcr1365
crossref_primary_10_1200_JCO_2013_54_8925
crossref_primary_10_1016_j_molonc_2009_02_001
crossref_primary_10_17650_2313_805X_2023_10_3_8_14
crossref_primary_10_1016_j_molonc_2009_02_004
crossref_primary_10_1097_CEJ_0000000000000493
crossref_primary_10_1200_JCO_2009_27_2294
crossref_primary_10_1002_mgg3_414
crossref_primary_10_1007_s13277_013_1348_0
crossref_primary_10_1111_j_1365_2796_2011_02502_x
crossref_primary_10_1007_s40142_021_00200_7
crossref_primary_10_1093_nop_npv026
crossref_primary_10_3390_cancers12040916
crossref_primary_10_1002_cncr_27864
crossref_primary_10_1007_s10549_010_1123_5
crossref_primary_10_1074_jbc_M111_327296
crossref_primary_10_1093_humrep_dem055
crossref_primary_10_1146_annurev_med_043015_075227
crossref_primary_10_1111_rssc_12091
crossref_primary_10_1038_ng_669
crossref_primary_10_1002_gepi_20074
crossref_primary_10_1007_s13193_011_0049_7
crossref_primary_10_1016_j_ygyno_2018_05_028
crossref_primary_10_1158_1055_9965_EPI_16_0341
crossref_primary_10_1159_000375390
crossref_primary_10_1038_s41576_019_0200_9
crossref_primary_10_2139_ssrn_3186407
crossref_primary_10_1089_gte_2007_0071
crossref_primary_10_1016_j_jmoldx_2016_03_005
crossref_primary_10_1007_s12672_017_0319_0
crossref_primary_10_1186_s13058_016_0739_8
crossref_primary_10_1038_ejhg_2014_161
crossref_primary_10_1111_cge_12505
crossref_primary_10_1016_j_ygyno_2021_04_014
crossref_primary_10_3389_fmolb_2018_00076
crossref_primary_10_1097_PPO_0b013e31826246c2
crossref_primary_10_3892_ol_2017_6725
crossref_primary_10_1016_j_ejphar_2022_174752
crossref_primary_10_1093_jncics_pky078
crossref_primary_10_1007_s10549_010_0769_3
crossref_primary_10_1016_j_ogc_2011_02_007
crossref_primary_10_1002_cam4_70321
crossref_primary_10_1245_s10434_015_4835_2
crossref_primary_10_1093_her_cyab011
crossref_primary_10_1016_j_clinbiochem_2015_10_009
crossref_primary_10_1016_j_jbc_2024_107686
crossref_primary_10_1093_jnci_djae306
crossref_primary_10_1080_00016340500324621
crossref_primary_10_1016_j_ejca_2020_12_023
crossref_primary_10_1016_S0246_1064_12_55503_9
crossref_primary_10_1007_s12687_010_0014_0
crossref_primary_10_1016_j_heliyon_2024_e38183
crossref_primary_10_1093_annonc_mdt327
crossref_primary_10_1097_PAT_0b013e32834e8e5b
crossref_primary_10_1158_0008_5472_CAN_10_0570
crossref_primary_10_1007_s11864_019_0685_7
crossref_primary_10_1007_s00439_013_1299_y
crossref_primary_10_1038_bmt_2016_82
crossref_primary_10_1002_humu_23818
crossref_primary_10_1155_2010_891059
crossref_primary_10_3389_fonc_2024_1514120
crossref_primary_10_1002_cncr_27842
crossref_primary_10_1007_s10549_021_06445_8
crossref_primary_10_1093_annonc_mdh474
crossref_primary_10_4143_crt_2019_351
crossref_primary_10_1200_JCO_2011_38_6060
crossref_primary_10_1016_j_pec_2005_10_007
crossref_primary_10_1007_s00103_013_1910_3
crossref_primary_10_1093_annonc_mdt311
crossref_primary_10_1038_sj_bjc_6605287
crossref_primary_10_1016_j_bulcan_2016_01_001
crossref_primary_10_1016_j_ogc_2013_05_003
crossref_primary_10_1016_j_ygyno_2018_12_014
crossref_primary_10_1093_jbi_wbad093
crossref_primary_10_1111_tog_12213
crossref_primary_10_1038_srep30026
crossref_primary_10_1093_annonc_mdt312
crossref_primary_10_1097_00055735_200404000_00002
crossref_primary_10_1016_j_ygyno_2017_06_002
crossref_primary_10_1200_JCO_2009_22_7991
crossref_primary_10_1214_20_AOAS1389
crossref_primary_10_2217_17455057_5_1_63
crossref_primary_10_1007_s11033_019_04659_0
crossref_primary_10_1016_j_ogc_2013_05_009
crossref_primary_10_1002_cncr_27839
crossref_primary_10_1038_nrc_2016_72
crossref_primary_10_1016_S1879_8543_09_70668_8
crossref_primary_10_1007_s12282_015_0618_7
crossref_primary_10_2174_1573404819666221021091708
crossref_primary_10_1016_j_breast_2022_10_009
crossref_primary_10_1093_jnci_djj132
crossref_primary_10_1007_s00432_017_2465_8
crossref_primary_10_1007_s10549_009_0390_5
crossref_primary_10_1200_JCO_19_00363
crossref_primary_10_1089_gte_2007_0031
crossref_primary_10_1038_s41598_022_05931_3
crossref_primary_10_1074_mcp_R400006_MCP200
crossref_primary_10_1111_j_1440_1673_2007_01907_x
crossref_primary_10_1158_0008_5472_CAN_07_5165
crossref_primary_10_1158_1078_0432_CCR_15_1465
crossref_primary_10_3390_cancers16010028
crossref_primary_10_1186_s13045_017_0466_3
crossref_primary_10_1007_s10549_011_1807_5
crossref_primary_10_1093_jnci_dji281
crossref_primary_10_18632_oncotarget_17225
crossref_primary_10_1101_sqb_2017_82_035006
crossref_primary_10_1007_s10689_011_9495_1
crossref_primary_10_1056_NEJMsb042979
crossref_primary_10_1056_NEJMra1503523
crossref_primary_10_1016_j_aquatox_2013_10_006
crossref_primary_10_1038_sj_bjc_6602199
crossref_primary_10_1007_s10897_016_0035_x
crossref_primary_10_1016_j_lanwpc_2024_101017
crossref_primary_10_1093_aje_kwv193
crossref_primary_10_1259_bjr_79950074
crossref_primary_10_1136_jmedgenet_2015_103077
crossref_primary_10_1007_s10897_014_9724_5
crossref_primary_10_1016_j_jpag_2010_02_004
crossref_primary_10_1016_j_bjps_2012_05_001
crossref_primary_10_1200_JCO_2011_39_7638
crossref_primary_10_1016_j_cpt_2024_04_002
crossref_primary_10_1016_j_socscimed_2019_112550
crossref_primary_10_1016_j_fertnstert_2017_03_018
crossref_primary_10_1097_PAS_0000000000001115
crossref_primary_10_1126_science_1091465
crossref_primary_10_12688_f1000research_9977_1
crossref_primary_10_1016_j_ejca_2018_10_022
crossref_primary_10_1002_humu_22972
crossref_primary_10_1136_bmjopen_2017_017675
crossref_primary_10_1038_bjc_2016_58
crossref_primary_10_1093_annonc_mdt384
crossref_primary_10_1157_13085493
crossref_primary_10_1016_j_humpath_2010_07_008
crossref_primary_10_1186_bcr3169
crossref_primary_10_1016_j_ctrv_2014_12_002
crossref_primary_10_1038_s10038_020_00849_y
crossref_primary_10_1371_journal_pgen_1001357
crossref_primary_10_3390_ijerph19138113
crossref_primary_10_1007_s10689_012_9596_5
crossref_primary_10_1016_j_jmoldx_2018_06_003
crossref_primary_10_1007_s10689_014_9740_5
crossref_primary_10_1016_j_erap_2021_100714
crossref_primary_10_1007_s10549_012_2158_6
crossref_primary_10_1016_S1283_081X_19_42497_1
crossref_primary_10_1245_s10434_017_5999_8
crossref_primary_10_5496_wjmg_v1_i1_14
crossref_primary_10_1007_s10897_014_9692_9
crossref_primary_10_1007_s12254_023_00921_1
crossref_primary_10_1097_GME_0000000000000724
crossref_primary_10_1186_s12885_020_6574_4
crossref_primary_10_1007_s10549_017_4552_6
crossref_primary_10_1016_j_jomh_2010_08_010
crossref_primary_10_1007_s12609_015_0181_4
crossref_primary_10_1038_sj_bjc_6604394
crossref_primary_10_1007_s10549_009_0359_4
crossref_primary_10_3390_ijms26010078
crossref_primary_10_1158_0008_5472_CAN_16_2025
crossref_primary_10_3390_genes12071100
crossref_primary_10_1016_j_ecl_2015_05_003
crossref_primary_10_1016_j_cca_2024_119992
crossref_primary_10_1007_s40142_015_0066_x
crossref_primary_10_1007_s10689_013_9697_9
crossref_primary_10_1093_carcin_bgab107
crossref_primary_10_1038_bjc_2016_32
crossref_primary_10_1016_j_ejso_2005_05_007
crossref_primary_10_1093_carcin_bgq069
crossref_primary_10_1002_path_4517
crossref_primary_10_1177_2381468318821103
crossref_primary_10_1007_s10689_008_9189_5
crossref_primary_10_1002_jmri_24243
crossref_primary_10_1016_j_currproblcancer_2018_01_001
crossref_primary_10_1016_S0025_6196_11_61196_8
crossref_primary_10_1111_j_1399_0004_2009_01329_x
crossref_primary_10_15406_jcpcr_2015_03_00100
crossref_primary_10_1016_j_medcli_2008_06_027
crossref_primary_10_1016_j_pec_2014_04_011
crossref_primary_10_3389_fonc_2023_1175617
crossref_primary_10_1016_S0246_1072_08_45340_3
crossref_primary_10_1590_1678_4685_gmb_2018_0104
crossref_primary_10_1016_j_jmoldx_2015_11_007
crossref_primary_10_4065_82_6_751
crossref_primary_10_1016_j_ctrv_2017_09_005
crossref_primary_10_1148_rg_2020190181
crossref_primary_10_5306_wjco_v8_i3_241
crossref_primary_10_1002_term_2999
crossref_primary_10_1007_s10689_015_9854_4
crossref_primary_10_24075_brsmu_2021_006
crossref_primary_10_1097_01_JAA_0000465220_96609_1d
crossref_primary_10_3390_pr10061107
crossref_primary_10_1016_j_gene_2021_146157
crossref_primary_10_18632_oncotarget_22962
crossref_primary_10_1038_nrc1890
crossref_primary_10_1148_radiol_2443051661
crossref_primary_10_1080_07347330802116051
crossref_primary_10_3390_cancers16173085
crossref_primary_10_1016_S2214_3106_15_30017_0
crossref_primary_10_1002_cncr_26480
crossref_primary_10_1007_s40944_017_0164_7
crossref_primary_10_1007_s10689_007_9151_y
crossref_primary_10_1016_j_fertnstert_2015_02_011
crossref_primary_10_1016_j_clon_2005_03_009
crossref_primary_10_7124_visnyk_utgis_18_1_2_1354
crossref_primary_10_1007_s10549_020_06038_x
crossref_primary_10_1007_s10549_011_1596_x
crossref_primary_10_1097_PPO_0b013e31819585f1
crossref_primary_10_1038_nrclinonc_2012_123
crossref_primary_10_1375_twin_13_1_43
crossref_primary_10_1093_jnci_djx282
crossref_primary_10_1093_jnci_djy132
crossref_primary_10_1155_2014_787143
crossref_primary_10_1007_s10549_017_4142_7
crossref_primary_10_1186_s13053_014_0023_9
crossref_primary_10_1038_nature23305
crossref_primary_10_1155_2012_709049
crossref_primary_10_1093_jnci_djy148
crossref_primary_10_1038_s41576_018_0018_x
crossref_primary_10_1158_1078_0432_CCR_07_5208
crossref_primary_10_1016_j_socscimed_2018_02_022
crossref_primary_10_1200_JCO_2005_03_6772
crossref_primary_10_3389_fgene_2021_676546
crossref_primary_10_1245_s10434_016_5479_6
crossref_primary_10_3390_cancers12092539
crossref_primary_10_1016_j_amjsurg_2009_06_010
crossref_primary_10_1542_peds_2018_1099H
crossref_primary_10_1007_s10549_017_4395_1
crossref_primary_10_1016_j_jmoldx_2013_07_004
crossref_primary_10_1016_j_ygyno_2017_04_013
crossref_primary_10_1245_s10434_016_5688_z
crossref_primary_10_3892_ol_2011_248
crossref_primary_10_1038_nrc1431
crossref_primary_10_1126_sciadv_aba4905
crossref_primary_10_3390_cancers14143469
crossref_primary_10_1186_2045_3701_3_11
crossref_primary_10_1007_s12282_014_0569_4
crossref_primary_10_1063_1_5050451
crossref_primary_10_1136_jmedgenet_2015_103132
crossref_primary_10_1002_cncr_29972
crossref_primary_10_4161_cbt_27628
crossref_primary_10_1016_S1479_666X_05_80042_3
crossref_primary_10_33145_2304_8336_2019_24_455_464
crossref_primary_10_1016_S0140_6736_18_30997_8
crossref_primary_10_1186_s13053_017_0085_6
crossref_primary_10_1517_17455057_1_1_027
crossref_primary_10_1016_j_jogoh_2018_05_008
crossref_primary_10_1093_jnci_djz008
crossref_primary_10_1158_1055_9965_EPI_06_0562
crossref_primary_10_1002_ijc_33234
crossref_primary_10_1038_onc_2014_332
crossref_primary_10_7314_APJCP_2015_16_17_7929
crossref_primary_10_1007_s10689_014_9766_8
crossref_primary_10_3390_app13084994
crossref_primary_10_1097_01_JAA_0000586384_47435_31
crossref_primary_10_1007_s10549_019_05359_w
crossref_primary_10_1186_s12885_022_10429_2
crossref_primary_10_1016_j_ejca_2013_02_018
crossref_primary_10_1016_j_currproblcancer_2014_10_003
crossref_primary_10_1038_s41523_022_00427_9
crossref_primary_10_1007_s10549_009_0394_1
crossref_primary_10_1056_NEJMoa1913948
crossref_primary_10_1007_s11912_023_01489_z
crossref_primary_10_1093_carcin_bgi136
crossref_primary_10_2217_bmt_12_22
crossref_primary_10_1371_journal_pgen_1008049
crossref_primary_10_1002_humu_22902
crossref_primary_10_1177_0300985810387939
crossref_primary_10_6339_24_JDS1127
crossref_primary_10_1016_j_semerg_2011_03_001
crossref_primary_10_1002_ijc_32396
crossref_primary_10_1016_j_amjsurg_2011_04_001
crossref_primary_10_29289_2594539420210041
crossref_primary_10_1007_s00761_011_2095_8
crossref_primary_10_1111_cge_13065
crossref_primary_10_1158_1055_9965_EPI_08_1034
crossref_primary_10_17650_2782_3202_2023_3_2_16_19
crossref_primary_10_3390_cancers11030416
crossref_primary_10_2217_bmt_12_25
crossref_primary_10_1007_s10549_015_3313_7
crossref_primary_10_1186_s12943_016_0546_y
crossref_primary_10_1146_annurev_med_010910_110221
crossref_primary_10_3390_life14081008
crossref_primary_10_1002_ijc_21273
crossref_primary_10_1016_j_ygyno_2015_07_100
crossref_primary_10_1155_2011_980158
crossref_primary_10_1002_gcc_23243
crossref_primary_10_1038_s41598_024_63300_8
crossref_primary_10_1111_j_1445_2197_2010_05581_x
crossref_primary_10_1093_oncolo_oyae214
crossref_primary_10_1007_s10549_018_05118_3
crossref_primary_10_1200_JCO_2003_10_100
crossref_primary_10_1007_s10689_015_9823_y
crossref_primary_10_1093_jjco_hyt036
crossref_primary_10_7717_peerj_2162
crossref_primary_10_1089_jwh_2023_0621
crossref_primary_10_1002_jmri_27781
crossref_primary_10_1007_s12282_015_0648_1
crossref_primary_10_3390_genes13030430
crossref_primary_10_1007_s10549_005_9049_z
crossref_primary_10_1007_s10549_013_2540_z
crossref_primary_10_1080_08870441003592587
crossref_primary_10_1007_s10689_012_9539_1
crossref_primary_10_1016_j_bcp_2012_07_024
crossref_primary_10_23736_S0026_4806_19_06091_9
crossref_primary_10_17656_jzs_10533
crossref_primary_10_1186_s13058_014_0474_y
crossref_primary_10_7554_eLife_80254
crossref_primary_10_1002_ar_22628
crossref_primary_10_1016_j_dnarep_2019_06_005
crossref_primary_10_1111_j_1471_0528_2011_02920_x
crossref_primary_10_7326_0003_4819_152_7_201004060_01004
crossref_primary_10_1089_jwh_2021_0113
crossref_primary_10_1093_abbs_gmw047
crossref_primary_10_1097_PRS_0000000000003577
crossref_primary_10_1007_s10549_007_9621_9
crossref_primary_10_1007_s10549_015_3459_3
crossref_primary_10_1016_j_jgyn_2008_05_013
crossref_primary_10_1371_journal_pone_0057173
crossref_primary_10_1016_S0001_4079_19_32379_9
crossref_primary_10_1007_s10549_010_1068_8
crossref_primary_10_1002_gepi_20493
crossref_primary_10_1002_mc_23798
crossref_primary_10_1097_01_PGO_0000364891_73439_70
crossref_primary_10_3917_reco_683_0379
crossref_primary_10_1002_gcc_20199
crossref_primary_10_1038_bjc_2013_769
crossref_primary_10_2174_1573405618666220415130131
crossref_primary_10_3802_jgo_2022_33_e46
crossref_primary_10_1093_hmg_ddr388
crossref_primary_10_1002_gepi_20007
crossref_primary_10_1016_j_soin_2013_04_003
crossref_primary_10_1038_s41571_020_0428_5
crossref_primary_10_1158_1055_9965_EPI_12_0149
crossref_primary_10_1016_j_jtbi_2016_05_013
crossref_primary_10_1016_j_molcel_2019_10_008
crossref_primary_10_1155_2011_374012
crossref_primary_10_1186_s12864_016_2842_8
crossref_primary_10_4161_cc_25695
crossref_primary_10_1007_s10549_014_2894_x
crossref_primary_10_1111_tbj_13007
crossref_primary_10_1002_cncr_30525
crossref_primary_10_3109_14647273_2014_940003
crossref_primary_10_1016_j_semradonc_2022_01_011
crossref_primary_10_1016_j_ygyno_2004_10_017
crossref_primary_10_1007_s10549_010_0868_1
crossref_primary_10_1111_bjh_18419
crossref_primary_10_1038_ng_2582
crossref_primary_10_1177_1049732310387798
crossref_primary_10_1007_s10689_009_9242_z
crossref_primary_10_1093_annonc_mdm274
crossref_primary_10_1200_PO_17_00286
crossref_primary_10_1038_sj_bjc_6603535
crossref_primary_10_2217_bmt_12_70
crossref_primary_10_1158_0008_5472_CAN_06_0503
crossref_primary_10_1586_14737159_6_4_627
crossref_primary_10_1016_j_clon_2005_05_009
crossref_primary_10_1038_nrc2349
crossref_primary_10_1002_humu_22025
crossref_primary_10_1111_cge_12174
crossref_primary_10_1136_jmedgenet_2016_103839
crossref_primary_10_1200_JCO_2008_19_9430
crossref_primary_10_4103_ajm_AJM_21_18
crossref_primary_10_1097_AOG_0b013e31818bba31
crossref_primary_10_1016_j_gim_2021_08_016
crossref_primary_10_3390_cancers13061378
crossref_primary_10_1007_s10689_017_0001_2
crossref_primary_10_1089_gte_2007_0525
crossref_primary_10_3389_fphar_2022_1014933
crossref_primary_10_1056_NEJMra1707939
crossref_primary_10_1111_j_1467_9566_2011_01427_x
crossref_primary_10_1134_S0026893307010050
crossref_primary_10_3389_fonc_2024_1358982
crossref_primary_10_1002_pon_1824
crossref_primary_10_1093_annonc_mdq628
crossref_primary_10_1007_s12609_016_0220_9
crossref_primary_10_2144_fsoa_2019_0089
crossref_primary_10_3390_cancers16101865
crossref_primary_10_1016_j_ejca_2004_05_004
crossref_primary_10_1051_radiopro_2017034
crossref_primary_10_2217_17455057_1_1_27
crossref_primary_10_1007_s10689_011_9425_2
crossref_primary_10_1038_sj_bjc_6603528
crossref_primary_10_3390_cancers10090309
crossref_primary_10_1038_s41598_023_51031_1
crossref_primary_10_1158_1055_9965_EPI_13_1380
crossref_primary_10_1080_08870446_2010_525640
crossref_primary_10_1186_bcr2796
crossref_primary_10_1200_JOP_2015_004838
crossref_primary_10_1038_sj_ejhg_5201895
crossref_primary_10_1186_1472_6874_10_28
crossref_primary_10_1007_s10689_020_00202_4
crossref_primary_10_1186_1472_6874_10_24
crossref_primary_10_1016_S1776_9817_04_94797_9
crossref_primary_10_1016_j_ejca_2005_11_020
crossref_primary_10_1016_j_cancergencyto_2006_03_010
crossref_primary_10_1016_j_bjps_2022_01_031
crossref_primary_10_1016_S1470_2045_06_70585_X
crossref_primary_10_1097_IGC_0b013e318257b936
crossref_primary_10_1016_j_csbj_2021_05_013
crossref_primary_10_1016_j_ejca_2012_07_021
crossref_primary_10_1146_annurev_publhealth_040617_014158
crossref_primary_10_1097_NUR_0000000000000118
crossref_primary_10_1016_j_cloc_2012_02_012
crossref_primary_10_1111_tbj_12521
crossref_primary_10_1093_jnci_djz079
crossref_primary_10_1016_j_adro_2020_01_006
crossref_primary_10_1371_journal_pgen_1006208
crossref_primary_10_1200_JCO_2011_37_1476
crossref_primary_10_1038_ejhg_2009_89
crossref_primary_10_1684_bdc_2012_1637
crossref_primary_10_1007_s10549_023_07135_3
crossref_primary_10_1186_bcr2785
crossref_primary_10_1136_ijgc_2019_001168
crossref_primary_10_1007_s10897_006_9078_8
crossref_primary_10_1016_j_biocel_2018_11_002
crossref_primary_10_1016_j_breast_2013_04_006
crossref_primary_10_1093_jnci_dji312
crossref_primary_10_1007_s00604_022_05595_w
crossref_primary_10_1016_j_ejca_2005_11_032
crossref_primary_10_4137_BCBCR_S18715
crossref_primary_10_1016_j_critrevonc_2006_12_004
crossref_primary_10_1038_sj_bjc_6603545
crossref_primary_10_1111_tbj_12519
crossref_primary_10_2967_jnumed_114_152496
crossref_primary_10_1002_pon_1850
crossref_primary_10_1007_s12687_013_0166_9
crossref_primary_10_1007_s00432_015_1986_2
crossref_primary_10_1097_CEJ_0b013e32832abd76
crossref_primary_10_1158_1055_9965_EPI_13_1364
crossref_primary_10_1200_PO_16_00066
crossref_primary_10_1136_jmg_2022_109104
crossref_primary_10_1371_journal_pone_0136419
crossref_primary_10_1136_bmjsrh_2018_CHC
crossref_primary_10_1038_s41467_020_17680_w
crossref_primary_10_1111_j_1399_0004_2008_00988_x
crossref_primary_10_1186_s12885_015_1931_4
crossref_primary_10_1186_s12885_021_08863_9
crossref_primary_10_1136_jmedgenet_2013_102015
crossref_primary_10_1016_j_soncn_2015_03_002
crossref_primary_10_1159_000376600
crossref_primary_10_1016_j_surg_2011_12_030
crossref_primary_10_1039_C8RA01919C
crossref_primary_10_1109_TCSS_2019_2912629
crossref_primary_10_1136_bmjopen_2019_031727
crossref_primary_10_4048_jbc_2011_14_S_S24
crossref_primary_10_1186_s12885_017_3422_2
crossref_primary_10_1576_toag_10_1_009_27371
crossref_primary_10_1016_j_molmed_2005_02_003
crossref_primary_10_1007_s10552_012_0022_y
crossref_primary_10_1158_1055_9965_2078_13_12
crossref_primary_10_1016_j_pec_2012_03_019
crossref_primary_10_1200_PO_16_00031
crossref_primary_10_1007_s10549_016_3836_6
crossref_primary_10_1111_IGC_0b013e3181a1b5dc
crossref_primary_10_1093_annonc_mdq660
crossref_primary_10_5734_JGM_2012_9_1_1
crossref_primary_10_1016_j_jogc_2018_05_046
crossref_primary_10_1016_j_patol_2016_05_004
crossref_primary_10_1097_IGC_0b013e31824b4093
crossref_primary_10_1097_PAS_0b013e31817d74a7
crossref_primary_10_1016_j_gde_2010_02_009
crossref_primary_10_1093_annonc_mdq663
crossref_primary_10_1177_1049732305284002
crossref_primary_10_1002_jgc4_1189
crossref_primary_10_2217_bmm_13_121
crossref_primary_10_4048_jbc_2011_14_S_S17
crossref_primary_10_1016_j_critrevonc_2019_01_016
crossref_primary_10_1136_bmjopen_2020_045075
crossref_primary_10_1093_jnci_djn180
crossref_primary_10_1158_1078_0432_CCR_07_5237
crossref_primary_10_1245_s10434_024_16484_2
crossref_primary_10_1111_cge_12149
crossref_primary_10_1016_j_jmwh_2005_02_008
crossref_primary_10_1177_15579883221074818
crossref_primary_10_1016_j_revmed_2004_11_012
crossref_primary_10_1515_biol_2022_0847
crossref_primary_10_1038_srep29506
crossref_primary_10_1080_07357907_2016_1227444
crossref_primary_10_12688_f1000research_10434_1
crossref_primary_10_15585_mmwr_mm6546a3
crossref_primary_10_1586_14737140_6_8_1205
crossref_primary_10_1016_j_ajhg_2022_01_019
crossref_primary_10_1007_s00129_019_4420_z
crossref_primary_10_1007_s10549_011_1539_6
crossref_primary_10_1038_s41525_020_0114_7
crossref_primary_10_1097_AOG_0000000000003562
crossref_primary_10_1016_j_bpobgyn_2022_03_001
crossref_primary_10_1111_j_1617_0830_2005_00041_x
crossref_primary_10_1186_s12881_019_0814_y
crossref_primary_10_3389_fendo_2022_844575
crossref_primary_10_1093_jnci_djz037
crossref_primary_10_1245_s10434_017_5915_2
crossref_primary_10_1016_j_clbc_2023_07_010
crossref_primary_10_1016_j_breastdis_2011_10_050
crossref_primary_10_1056_NEJMra035692
crossref_primary_10_1016_j_ejca_2010_04_018
crossref_primary_10_1200_EDBK_100001
crossref_primary_10_1016_j_canep_2013_11_004
crossref_primary_10_1371_journal_pgen_1010739
crossref_primary_10_1093_annonc_mdp316
crossref_primary_10_4048_jbc_2009_12_2_92
crossref_primary_10_1517_13543784_2016_1156857
crossref_primary_10_3389_fgene_2020_552971
crossref_primary_10_1007_s10689_015_9827_7
crossref_primary_10_1016_j_critrevonc_2005_05_003
crossref_primary_10_1111_tbj_13400
crossref_primary_10_1007_s10897_015_9877_x
crossref_primary_10_1016_j_ajog_2022_02_022
crossref_primary_10_1007_s10897_015_9899_4
crossref_primary_10_1200_PO_16_00021
crossref_primary_10_3390_life14111451
crossref_primary_10_1002_ijc_28537
crossref_primary_10_1158_1078_0432_CCR_1029_3
crossref_primary_10_1007_s10897_012_9569_8
crossref_primary_10_1097_GME_0000000000002168
crossref_primary_10_1097_IGC_0000000000000791
crossref_primary_10_1007_s10985_007_9070_0
crossref_primary_10_1118_1_4927260
crossref_primary_10_18632_oncotarget_8272
crossref_primary_10_1016_j_dnarep_2020_102957
crossref_primary_10_1093_annonc_mdn527
crossref_primary_10_1007_s10549_007_9729_y
crossref_primary_10_3390_jpm11090847
crossref_primary_10_1783_147118906777888440
crossref_primary_10_1002_pbc_27397
crossref_primary_10_1038_bjc_2011_91
crossref_primary_10_1016_j_mgene_2019_100596
crossref_primary_10_1016_j_spinee_2015_10_053
crossref_primary_10_1016_j_yao_2022_02_001
crossref_primary_10_1002_ijc_26369
crossref_primary_10_1136_ijgc_2020_002071
crossref_primary_10_17795_gct_28416
crossref_primary_10_1111_his_13503
crossref_primary_10_1007_s10689_013_9625_z
crossref_primary_10_1007_s12609_009_0018_0
crossref_primary_10_3389_fimmu_2024_1407837
crossref_primary_10_3390_genes10020153
crossref_primary_10_1007_s10549_017_4115_x
crossref_primary_10_1186_s12935_020_01500_8
crossref_primary_10_1287_deca_2017_0352
crossref_primary_10_51620_0869_2084_2021_66_12_760_767
crossref_primary_10_1016_j_yao_2022_02_006
crossref_primary_10_1097_CCO_0b013e3283499da9
crossref_primary_10_4137_CIN_S618
crossref_primary_10_1097_GCO_0b013e328332dca3
crossref_primary_10_1158_1055_9965_EPI_09_0024
crossref_primary_10_1007_s10689_011_9467_5
crossref_primary_10_1515_tjb_2019_0424
crossref_primary_10_7774_cevr_2022_11_2_163
crossref_primary_10_1007_s10549_025_07657_y
crossref_primary_10_1016_S1472_6483_10_60144_7
crossref_primary_10_1016_j_clbc_2018_09_011
crossref_primary_10_1016_j_femme_2013_04_003
crossref_primary_10_1016_S1535_6108_03_00111_9
crossref_primary_10_1002_mgg3_2071
crossref_primary_10_1016_j_dnarep_2017_06_007
crossref_primary_10_1016_j_patol_2015_12_009
crossref_primary_10_1002_humu_20261
crossref_primary_10_1200_JCO_2005_96_009
crossref_primary_10_1371_journal_pgen_1003212
crossref_primary_10_1002_mgg3_359
crossref_primary_10_1530_ERC_16_0228
crossref_primary_10_1007_s10897_012_9547_1
crossref_primary_10_3390_cancers13215552
crossref_primary_10_5005_jpmer_53_4_iii
crossref_primary_10_1016_j_maturitas_2015_07_001
crossref_primary_10_1200_JCO_2009_24_2495
crossref_primary_10_1038_modpathol_2016_135
crossref_primary_10_1016_j_cpcardiol_2019_04_001
crossref_primary_10_1093_jnci_djae030
crossref_primary_10_1111_j_1365_2303_2010_00773_x
crossref_primary_10_26453_otjhs_459624
crossref_primary_10_3390_ijms242115507
crossref_primary_10_1038_s41388_020_01482_x
crossref_primary_10_1097_GRF_0000000000000313
crossref_primary_10_1038_s41431_024_01704_w
crossref_primary_10_1093_jjco_hyv190
crossref_primary_10_1007_s10689_008_9216_6
crossref_primary_10_1007_s12609_013_0117_9
crossref_primary_10_1097_GRF_0000000000000315
crossref_primary_10_1097_GRF_0000000000000318
crossref_primary_10_1158_1078_0432_CCR_07_0689
crossref_primary_10_1007_s12609_012_0091_7
crossref_primary_10_1016_j_currproblcancer_2016_09_007
crossref_primary_10_1097_GRF_0000000000000319
crossref_primary_10_3109_01443615_2012_668579
crossref_primary_10_1158_1940_6207_CAPR_11_0547
crossref_primary_10_1002_cam4_5288
crossref_primary_10_1200_JCO_2008_21_4684
crossref_primary_10_1089_gte_2006_0525
crossref_primary_10_1016_j_ctrc_2016_03_004
crossref_primary_10_1038_modpathol_2016_145
crossref_primary_10_1089_gte_2007_0101
crossref_primary_10_1080_10810730_2011_551993
crossref_primary_10_1186_bcr1040
crossref_primary_10_1089_cbr_2020_4249
crossref_primary_10_1093_carcin_bgx010
crossref_primary_10_1097_PAS_0b013e3181bc6059
crossref_primary_10_1038_s41467_017_00388_9
crossref_primary_10_3923_rjmsci_2012_83_86
crossref_primary_10_1016_j_dnarep_2020_102994
crossref_primary_10_2147_IJGM_S335592
crossref_primary_10_1002_humu_20283
crossref_primary_10_1016_j_ejmg_2007_11_001
crossref_primary_10_1038_nrc2037
crossref_primary_10_1093_annonc_mdm234
crossref_primary_10_5306_wjco_v15_i12_1481
crossref_primary_10_1038_sj_bjc_6602488
crossref_primary_10_1002_jgc4_1218
crossref_primary_10_3844_ajassp_2011_1_8
crossref_primary_10_1038_s41419_020_03013_8
crossref_primary_10_1007_s00432_015_2051_x
crossref_primary_10_1111_j_1547_5069_2005_00021_x
crossref_primary_10_1007_s10549_016_3870_4
crossref_primary_10_1186_bcr3218
crossref_primary_10_1007_s10689_016_9898_0
crossref_primary_10_1007_s10897_014_9695_6
crossref_primary_10_5306_wjco_v5_i3_283
crossref_primary_10_1007_s12312_013_1041_7
crossref_primary_10_1093_nar_gkab308
crossref_primary_10_1097_GCO_0b013e32821642d1
crossref_primary_10_15446_rsap_v20n2_64866
crossref_primary_10_1007_s10549_017_4595_8
crossref_primary_10_21518_2079_701X_2020_9_248_257
crossref_primary_10_5124_jkma_2009_52_10_952
crossref_primary_10_1515_hmbci_2017_0025
crossref_primary_10_1016_j_jmig_2018_09_767
crossref_primary_10_2217_cpr_13_72
crossref_primary_10_1093_sw_sws052
crossref_primary_10_1111_tbj_12978
crossref_primary_10_1016_j_biotechadv_2017_12_002
crossref_primary_10_1038_jhg_2012_127
crossref_primary_10_1007_s12687_021_00518_3
crossref_primary_10_1111_j_1048_891X_2004_14503_x
crossref_primary_10_1136_ijgc_2022_003913
crossref_primary_10_1007_s10689_014_9706_7
crossref_primary_10_1016_j_cdip_2004_03_005
crossref_primary_10_1186_1897_4287_3_2_71
crossref_primary_10_1186_bcr1025
crossref_primary_10_1007_s10897_012_9493_y
crossref_primary_10_1002_cncr_34464
crossref_primary_10_4236_abcr_2015_44010
crossref_primary_10_1080_15257770_2021_1944637
crossref_primary_10_1016_j_clon_2018_03_036
crossref_primary_10_1007_s10689_017_9977_x
crossref_primary_10_1007_s10549_009_0476_0
crossref_primary_10_1016_j_toxlet_2009_04_006
crossref_primary_10_1038_nrc2054
crossref_primary_10_2196_11287
crossref_primary_10_14229_onco_2023_09_20_010
crossref_primary_10_1056_NEJMra1407390
crossref_primary_10_1200_EDBK_158817
crossref_primary_10_1007_s10897_006_9026_7
crossref_primary_10_1007_s10689_012_9577_8
crossref_primary_10_1007_s00761_016_0075_8
crossref_primary_10_1016_j_mce_2005_09_014
crossref_primary_10_1097_RMR_0b013e3180417d8e
crossref_primary_10_17816_onco39998
crossref_primary_10_1007_s10689_010_9362_5
crossref_primary_10_1007_s10689_017_9999_4
crossref_primary_10_1016_j_ygyno_2019_06_017
crossref_primary_10_1007_s10897_007_9105_4
crossref_primary_10_4048_jbc_2017_20_4_386
crossref_primary_10_1038_sj_bjc_6603358
crossref_primary_10_1002_pon_3703
crossref_primary_10_1002_ijc_22817
crossref_primary_10_1016_j_dnarep_2007_10_002
crossref_primary_10_1016_j_ygyno_2022_12_015
crossref_primary_10_1001_jama_2019_10987
crossref_primary_10_1186_s12916_023_03233_7
crossref_primary_10_1007_s10689_016_9876_6
crossref_primary_10_1016_j_ejca_2006_01_057
crossref_primary_10_1007_s10689_013_9621_3
crossref_primary_10_1371_journal_pone_0002024
crossref_primary_10_32708_uutfd_731913
crossref_primary_10_1016_j_maturitas_2011_10_008
crossref_primary_10_17730_1938_3525_80_3_203
crossref_primary_10_1007_s10897_016_9973_6
crossref_primary_10_1016_j_hoc_2010_06_004
crossref_primary_10_1016_S1776_9817_07_92168_9
crossref_primary_10_1002_cncr_21148
crossref_primary_10_3390_cancers12123732
crossref_primary_10_1007_s10549_012_2202_6
crossref_primary_10_1200_JCO_2006_06_7934
crossref_primary_10_1111_cge_12405
crossref_primary_10_3349_ymj_2021_62_12_1090
crossref_primary_10_1016_j_ctrv_2018_06_004
crossref_primary_10_1080_14733400500178592
crossref_primary_10_1016_j_ogc_2012_02_006
crossref_primary_10_1530_ERC_16_0277
crossref_primary_10_1200_JCO_2004_07_179
crossref_primary_10_1208_s12249_024_02755_4
crossref_primary_10_1186_1897_4287_3_2_53
crossref_primary_10_1038_nrclinonc_2016_90
crossref_primary_10_1158_1055_9965_EPI_05_0793
crossref_primary_10_1007_s10198_021_01396_9
crossref_primary_10_1002_14651858_CD012894_pub2
crossref_primary_10_1038_bjc_2011_1
crossref_primary_10_1016_j_ygyno_2008_07_018
crossref_primary_10_3390_cancers14122950
crossref_primary_10_3390_diagnostics11020370
crossref_primary_10_1042_BSR20182471
crossref_primary_10_1016_j_breast_2023_103620
crossref_primary_10_1111_j_1399_0004_2010_01604_x
crossref_primary_10_1016_j_ejca_2014_11_022
crossref_primary_10_1016_j_ygyno_2018_08_005
crossref_primary_10_1177_0193945913519870
crossref_primary_10_1371_journal_pone_0069851
crossref_primary_10_1158_1055_9965_1146_13_7
crossref_primary_10_1007_s11136_015_1181_6
crossref_primary_10_1186_s13053_016_0052_7
crossref_primary_10_1186_s12913_017_2802_2
crossref_primary_10_1016_j_ejogrb_2022_03_040
crossref_primary_10_1002_ijc_21988
crossref_primary_10_1038_s41467_017_00634_0
crossref_primary_10_1007_s10549_006_9378_6
crossref_primary_10_1007_s10198_007_0042_9
crossref_primary_10_1158_0008_5472_CAN_16_2568
crossref_primary_10_2139_ssrn_3139779
crossref_primary_10_1016_j_fertnstert_2021_02_030
crossref_primary_10_5567_pharmacologia_2012_352_361
crossref_primary_10_1038_srep43435
crossref_primary_10_1186_1471_2407_13_510
crossref_primary_10_1093_jbi_wbae037
crossref_primary_10_1159_000439110
crossref_primary_10_1016_j_ygyno_2015_01_537
crossref_primary_10_1159_000533428
crossref_primary_10_1200_JCO_2010_28_7334
crossref_primary_10_1016_S0140_6736_05_67570_8
crossref_primary_10_1016_j_ejca_2004_09_008
crossref_primary_10_1002_ijc_32655
crossref_primary_10_3389_fcell_2020_564601
crossref_primary_10_1007_s10689_010_9384_z
crossref_primary_10_1111_tog_12107
crossref_primary_10_1007_s10147_021_02098_1
crossref_primary_10_1002_bies_202300166
crossref_primary_10_1200_JCO_2016_71_6480
crossref_primary_10_1016_j_ygyno_2009_02_017
crossref_primary_10_1158_1055_9965_1683_13_11
crossref_primary_10_1200_JCO_2010_28_0719
crossref_primary_10_1016_j_ygyno_2018_04_564
crossref_primary_10_1038_nrclinonc_2016_66
crossref_primary_10_2139_ssrn_4183362
crossref_primary_10_1093_annonc_mdh352
crossref_primary_10_1159_000090908
crossref_primary_10_1007_s12325_016_0281_1
crossref_primary_10_1016_j_ygyno_2016_07_094
crossref_primary_10_1016_j_ygyno_2005_06_065
crossref_primary_10_1038_bjc_2013_741
crossref_primary_10_1200_JCO_2007_13_2118
crossref_primary_10_1016_j_gmit_2015_08_005
crossref_primary_10_1007_s10549_010_0877_0
crossref_primary_10_1111_tbj_12083
crossref_primary_10_1158_1078_0432_CCR_08_3128
crossref_primary_10_1136_jmedgenet_2012_101415
crossref_primary_10_1186_1471_2407_8_214
crossref_primary_10_1007_s13277_013_1009_3
crossref_primary_10_1371_journal_pone_0265052
crossref_primary_10_5005_jp_journals_10009_1150
crossref_primary_10_7124_bc_000962
crossref_primary_10_1007_s10897_017_0090_y
crossref_primary_10_1172_JCI20113
crossref_primary_10_1002_14651858_CD011210
crossref_primary_10_1007_s10897_018_0214_z
crossref_primary_10_1002_jso_21664
crossref_primary_10_2217_pgs_2019_0191
crossref_primary_10_3390_cancers11020193
crossref_primary_10_1016_S1776_9817_06_73059_0
crossref_primary_10_1038_bjc_2013_730
crossref_primary_10_1037_0278_6133_24_4_S78
crossref_primary_10_2174_1871520623666230821124008
crossref_primary_10_1002_ajmg_a_37783
crossref_primary_10_1016_j_adaj_2016_01_002
crossref_primary_10_1080_13697137_2023_2173567
crossref_primary_10_3892_ol_2017_7717
crossref_primary_10_3389_fvets_2017_00194
crossref_primary_10_1016_j_ejso_2021_03_248
crossref_primary_10_1007_s10552_012_9975_0
crossref_primary_10_1002_cam4_1251
crossref_primary_10_3390_jpm11020149
crossref_primary_10_1007_s11845_014_1238_5
crossref_primary_10_1002_cncr_25595
crossref_primary_10_4048_jbc_2008_11_2_95
crossref_primary_10_1200_JCO_2012_47_8313
crossref_primary_10_1002_pon_1582
crossref_primary_10_1007_s10815_020_01783_w
crossref_primary_10_3816_COC_2009_n_015
crossref_primary_10_3390_cancers15041072
crossref_primary_10_1007_s10549_021_06108_8
crossref_primary_10_1016_j_jmig_2020_09_020
crossref_primary_10_1186_s12885_023_10956_6
crossref_primary_10_4048_jbc_2007_10_4_241
crossref_primary_10_1016_j_breast_2012_12_005
crossref_primary_10_1007_s10549_020_05849_2
crossref_primary_10_1097_igc_0000000000001144
crossref_primary_10_3389_fbioe_2022_953887
crossref_primary_10_5468_ogs_24054
crossref_primary_10_1148_rg_2017160144
crossref_primary_10_1684_bdc_2013_1856
crossref_primary_10_1186_s12967_021_02772_y
crossref_primary_10_1016_j_semcancer_2022_10_003
crossref_primary_10_18027_2224_5057_2021_11_2_38_44
crossref_primary_10_1158_1055_9965_98_14_1
crossref_primary_10_1186_1897_4287_4_1_7
crossref_primary_10_1093_humrep_den471
crossref_primary_10_1038_s41598_022_16687_1
crossref_primary_10_1080_13697137_2016_1209396
crossref_primary_10_1007_s12282_015_0619_6
crossref_primary_10_1016_j_esmoop_2022_100459
crossref_primary_10_1016_j_critrevonc_2008_06_003
crossref_primary_10_1007_s10549_005_5150_6
crossref_primary_10_3389_fendo_2019_00235
crossref_primary_10_1093_nargab_lqac025
crossref_primary_10_1007_s11033_012_2484_0
crossref_primary_10_1111_ahg_12577
crossref_primary_10_1007_s10689_013_9687_y
crossref_primary_10_1684_bdc_2014_2036
crossref_primary_10_1016_j_semcancer_2017_12_008
crossref_primary_10_1097_PRS_0000000000008984
crossref_primary_10_1016_j_bbcan_2011_05_002
crossref_primary_10_1016_j_ogc_2017_10_011
crossref_primary_10_1158_1055_9965_EPI_05_0709
crossref_primary_10_1158_1940_6207_CAPR_15_0291
crossref_primary_10_1055_s_0034_1370167
crossref_primary_10_1016_j_humpath_2012_02_002
crossref_primary_10_1200_JCO_2013_52_8331
crossref_primary_10_1007_s10549_006_9441_3
crossref_primary_10_1016_j_ygyno_2016_03_007
crossref_primary_10_1002_cncr_26424
crossref_primary_10_1007_s10815_023_02939_0
crossref_primary_10_14694_EdBook_AM_2015_35_57
crossref_primary_10_1007_s00268_018_04897_6
crossref_primary_10_1200_JCO_2014_56_6232
crossref_primary_10_1007_s10549_010_0923_y
crossref_primary_10_1016_j_ygyno_2005_04_041
crossref_primary_10_1177_147323000703500417
crossref_primary_10_1007_s00439_017_1798_3
crossref_primary_10_1111_j_1399_0004_2012_01859_x
crossref_primary_10_1158_1055_9965_EPI_07_2792
crossref_primary_10_1002_gcc_22221
crossref_primary_10_1007_s12529_018_9722_3
crossref_primary_10_1097_01_prs_0000217383_99038_f5
crossref_primary_10_1007_s10897_017_0130_7
crossref_primary_10_1007_s10911_011_9213_5
crossref_primary_10_1016_j_ejca_2005_02_034
crossref_primary_10_1007_s12687_019_00415_w
crossref_primary_10_1097_MD_0000000000013187
crossref_primary_10_1016_j_rcl_2010_06_011
crossref_primary_10_1016_j_rcl_2010_06_012
crossref_primary_10_1038_nature12981
crossref_primary_10_3390_healthcare4010006
crossref_primary_10_1016_j_cell_2010_03_012
crossref_primary_10_1245_ASO_2004_09_910
crossref_primary_10_3389_fonc_2016_00108
crossref_primary_10_1007_s10549_011_1509_z
crossref_primary_10_1089_jwh_2013_4407
crossref_primary_10_2353_jmoldx_2009_090078
crossref_primary_10_15263_jlmqa_2022_44_4_216
crossref_primary_10_1007_s10549_009_0316_2
crossref_primary_10_18632_oncotarget_5693
crossref_primary_10_4174_astr_2024_107_6_327
crossref_primary_10_1007_s10689_012_9560_4
crossref_primary_10_1002_cncr_24199
crossref_primary_10_1016_j_molonc_2010_04_011
crossref_primary_10_1016_j_ygyno_2021_06_009
crossref_primary_10_1200_PO_24_00204
crossref_primary_10_1371_journal_pone_0127895
crossref_primary_10_3390_cancers13061417
crossref_primary_10_1016_j_ygyno_2006_06_032
crossref_primary_10_1007_s10549_011_1607_y
crossref_primary_10_1007_s00129_008_2277_7
crossref_primary_10_1007_s10897_017_0187_3
crossref_primary_10_3390_cells14050375
crossref_primary_10_4174_astr_2019_97_3_113
crossref_primary_10_1007_s10549_008_0117_z
crossref_primary_10_1073_pnas_1415979111
crossref_primary_10_1016_j_ogc_2007_10_001
crossref_primary_10_1159_000505449
crossref_primary_10_1007_s10689_024_00379_y
crossref_primary_10_1002_jso_23791
crossref_primary_10_1038_s41598_017_16138_2
crossref_primary_10_1093_ije_dyl003
crossref_primary_10_2353_jmoldx_2008_070161
crossref_primary_10_61186_ijbd_17_1_116
crossref_primary_10_1007_s12609_009_0022_4
crossref_primary_10_1016_j_jmoldx_2017_07_003
crossref_primary_10_1007_s10552_004_2593_8
crossref_primary_10_1016_j_ejogrb_2023_11_008
crossref_primary_10_1038_s41598_020_74250_2
crossref_primary_10_1016_j_gofs_2018_08_006
crossref_primary_10_1007_s10549_019_05345_2
crossref_primary_10_1007_s10549_010_1319_8
crossref_primary_10_1007_s10549_016_3777_0
crossref_primary_10_1007_s10897_009_9245_9
crossref_primary_10_1007_s00404_017_4546_y
crossref_primary_10_1080_0284186X_2018_1529428
crossref_primary_10_1007_s10689_007_9150_z
crossref_primary_10_1007_s10689_007_9172_6
crossref_primary_10_1016_j_ogc_2018_09_002
crossref_primary_10_1016_j_ygyno_2005_11_026
crossref_primary_10_1038_jhg_2016_138
crossref_primary_10_1371_journal_pone_0037891
crossref_primary_10_1371_journal_pone_0195497
crossref_primary_10_3389_fgene_2021_661109
crossref_primary_10_3390_cancers13092192
crossref_primary_10_1016_j_jogc_2018_09_001
crossref_primary_10_1016_j_ygyno_2023_11_022
crossref_primary_10_1245_s10434_014_3883_3
crossref_primary_10_1007_s10689_010_9327_8
crossref_primary_10_1245_s10434_014_3532_x
crossref_primary_10_1530_ERC_11_0338
crossref_primary_10_1007_s10269_009_1818_6
crossref_primary_10_1200_JCO_2005_03_3126
crossref_primary_10_1007_BF03256234
crossref_primary_10_1038_s41598_021_87698_7
crossref_primary_10_1200_JCO_2010_34_4440
crossref_primary_10_1016_S0001_4079_19_30227_4
crossref_primary_10_1097_SLA_0b013e318214b55a
crossref_primary_10_1158_1055_9965_EPI_12_0229
crossref_primary_10_2217_fon_13_278
crossref_primary_10_1517_14740338_2014_951327
crossref_primary_10_3389_fcell_2020_574466
crossref_primary_10_3945_ajcn_116_133470
crossref_primary_10_1093_annonc_mdq161
crossref_primary_10_1080_03461238_2010_482188
crossref_primary_10_51847_asgta1QMY9
crossref_primary_10_1172_JCI40577
crossref_primary_10_1200_JCO_2012_44_1238
crossref_primary_10_1016_j_pec_2017_08_008
crossref_primary_10_1016_j_mrrev_2017_08_001
crossref_primary_10_1016_j_ygyno_2015_08_024
crossref_primary_10_1093_jbi_wbab001
crossref_primary_10_1021_pr070041v
crossref_primary_10_1002_pon_3257
crossref_primary_10_1007_s12687_018_0378_0
crossref_primary_10_1080_03461238_2010_482191
crossref_primary_10_1007_s13691_024_00685_3
crossref_primary_10_1111_tbj_12056
crossref_primary_10_36290_xon_2017_043
crossref_primary_10_1093_bfgp_elt019
crossref_primary_10_1200_JGO_18_00066
crossref_primary_10_1186_s12885_015_1597_y
crossref_primary_10_1002_ijc_23340
crossref_primary_10_1007_s00330_013_2993_9
crossref_primary_10_1016_j_hoc_2022_08_004
crossref_primary_10_1111_imj_13357
crossref_primary_10_1177_1755738016685893
crossref_primary_10_1016_j_femme_2016_04_009
crossref_primary_10_1111_j_1524_4741_2009_00690_x
crossref_primary_10_3892_ol_2011_390
crossref_primary_10_1016_j_coph_2023_102381
crossref_primary_10_1016_j_gyobfe_2015_09_012
crossref_primary_10_3389_fgene_2021_742578
crossref_primary_10_5734_JGM_2010_7_1_67
crossref_primary_10_1007_s10549_009_0601_0
crossref_primary_10_1038_bjc_2014_458
crossref_primary_10_1158_1541_7786_MCR_06_0250
crossref_primary_10_3390_cancers15051625
crossref_primary_10_1007_s10689_015_9811_2
crossref_primary_10_1016_j_ygyno_2013_05_003
crossref_primary_10_2478_bjmg_2018_0004
crossref_primary_10_1177_0003134820964208
crossref_primary_10_1002_ijc_21176
crossref_primary_10_1007_s12253_011_9482_8
crossref_primary_10_1016_j_cancergencyto_2007_08_009
crossref_primary_10_3390_diagnostics10050269
crossref_primary_10_1080_14461242_2014_999402
crossref_primary_10_1093_humupd_dml027
crossref_primary_10_3390_cancers14122860
crossref_primary_10_1016_j_ygyno_2015_08_006
crossref_primary_10_4048_jbc_2019_22_e47
crossref_primary_10_1080_13697137_2017_1285879
crossref_primary_10_3390_vetsci10060379
crossref_primary_10_1007_s10897_006_9053_4
crossref_primary_10_1007_s10689_017_0059_x
crossref_primary_10_1111_j_1399_0004_2012_01855_x
crossref_primary_10_18632_oncotarget_26810
crossref_primary_10_1038_s41598_017_05056_y
crossref_primary_10_18632_oncotarget_24638
crossref_primary_10_1007_s40944_019_0280_7
crossref_primary_10_1016_j_bpobgyn_2005_10_017
crossref_primary_10_1007_s10354_010_0772_7
crossref_primary_10_1016_j_bpobgyn_2005_10_016
crossref_primary_10_1016_j_rcl_2017_06_011
crossref_primary_10_1016_j_tjog_2022_07_010
crossref_primary_10_1007_s12160_008_9060_9
crossref_primary_10_1016_S1548_5315_11_70558_7
crossref_primary_10_1101_cshperspect_a026542
crossref_primary_10_1038_ejhg_2016_92
crossref_primary_10_1038_ejhg_2016_93
crossref_primary_10_1007_s11812_017_0086_4
crossref_primary_10_3390_ijms14010640
crossref_primary_10_1007_s10689_004_9550_2
crossref_primary_10_3390_curroncol32020090
crossref_primary_10_1016_j_jmoldx_2014_11_004
crossref_primary_10_3389_fpsyg_2022_840931
crossref_primary_10_1007_s10439_021_02800_4
crossref_primary_10_1016_j_clbc_2018_07_015
crossref_primary_10_1016_j_jtcvs_2012_12_064
crossref_primary_10_1158_1055_9965_EPI_17_0516
crossref_primary_10_1200_JCO_2004_00_4960
crossref_primary_10_1097_PRS_0000000000009383
crossref_primary_10_1517_14656566_8_14_2293
crossref_primary_10_1007_s10549_007_9759_5
crossref_primary_10_1038_nrc2466
crossref_primary_10_17352_2455_8591_000021
crossref_primary_10_1159_000505854
crossref_primary_10_1111_j_1525_1438_2006_00287_x
crossref_primary_10_1158_1940_6207_CAPR_12_0190
crossref_primary_10_1007_s11845_015_1267_8
crossref_primary_10_1016_j_breast_2022_07_012
crossref_primary_10_1007_s10689_007_9154_8
crossref_primary_10_1038_sj_bjc_6603409
crossref_primary_10_1186_s12885_022_09780_1
crossref_primary_10_1186_1897_4287_3_4_179
crossref_primary_10_1097_01_pgp_0000228142_52054_0f
crossref_primary_10_1111_j_1369_7625_2008_00494_x
crossref_primary_10_1097_MD_0000000000030576
crossref_primary_10_1158_1055_9965_EPI_06_0829
crossref_primary_10_1093_annonc_mdl281
crossref_primary_10_1126_science_1088759
crossref_primary_10_1007_s10549_015_3658_y
crossref_primary_10_1016_j_ogc_2021_11_009
crossref_primary_10_1158_1078_0432_CCR_07_0711
crossref_primary_10_12968_bjon_2020_29_10_S6
crossref_primary_10_1007_s10269_010_1877_8
crossref_primary_10_1097_PPO_0b013e318260946f
crossref_primary_10_2143_AST_38_2_2033352
crossref_primary_10_1016_j_breast_2019_03_011
crossref_primary_10_3917_cont_047_0113
crossref_primary_10_1016_j_ygyno_2016_08_336
crossref_primary_10_1007_s11864_017_0468_y
crossref_primary_10_1111_cge_12037
crossref_primary_10_3390_genes9120586
crossref_primary_10_3390_healthcare4030035
crossref_primary_10_1200_JCO_2012_46_1905
crossref_primary_10_1080_14768320500230318
crossref_primary_10_1177_2292550319880912
crossref_primary_10_1016_j_ejca_2005_06_007
crossref_primary_10_1016_j_ejogrb_2021_08_001
crossref_primary_10_3389_fgene_2023_1248492
crossref_primary_10_1007_s10689_011_9437_y
crossref_primary_10_1007_s10897_014_9762_z
crossref_primary_10_1007_s10911_025_09578_4
crossref_primary_10_1038_bjc_2013_295
crossref_primary_10_1080_00981380802173509
crossref_primary_10_2105_AJPH_2005_083014
crossref_primary_10_1007_s10549_016_4018_2
crossref_primary_10_1016_j_ygyno_2021_08_021
crossref_primary_10_1111_j_1365_2559_2010_03642_x
crossref_primary_10_1186_s12885_015_1821_9
crossref_primary_10_1186_s12881_017_0448_x
crossref_primary_10_1186_bcr2414
crossref_primary_10_3389_fphar_2023_1199883
crossref_primary_10_47429_lmo_2021_11_4_283
crossref_primary_10_1371_journal_pone_0169673
crossref_primary_10_1016_j_hoc_2018_07_002
crossref_primary_10_1158_0008_5472_CAN_05_3368
crossref_primary_10_1007_s10549_024_07377_9
crossref_primary_10_1053_j_gastro_2009_07_039
crossref_primary_10_1016_j_ygyno_2009_06_012
crossref_primary_10_1017_S0515036100015270
crossref_primary_10_1148_radiol_2019181814
crossref_primary_10_1038_s41467_020_17374_3
crossref_primary_10_1186_s40001_019_0391_8
crossref_primary_10_1002_cncr_29041
crossref_primary_10_1111_j_1399_0004_2008_01117_x
crossref_primary_10_1016_j_ygyno_2008_11_039
crossref_primary_10_1039_C8MO00126J
crossref_primary_10_1111_cge_12497
crossref_primary_10_1002_path_4273
crossref_primary_10_1016_j_tibs_2018_10_008
crossref_primary_10_18632_oncotarget_12699
crossref_primary_10_1016_j_arr_2021_101488
crossref_primary_10_1007_s13193_023_01749_1
crossref_primary_10_1097_GCO_0000000000000141
crossref_primary_10_1136_jcp_2022_208461
crossref_primary_10_1158_1055_9965_EPI_07_0565
crossref_primary_10_1016_j_clbc_2017_12_005
crossref_primary_10_1016_j_pmedr_2023_102356
crossref_primary_10_1016_j_maturitas_2020_08_011
crossref_primary_10_1097_GME_0000000000002136
crossref_primary_10_1016_j_ygyno_2019_10_026
crossref_primary_10_1038_nnano_2008_91
crossref_primary_10_3892_ol_2015_3862
crossref_primary_10_1093_hmg_ddw094
crossref_primary_10_1186_1471_2210_11_7
crossref_primary_10_1186_1471_2407_12_246
crossref_primary_10_1186_s13048_021_00878_x
crossref_primary_10_1038_bjc_2011_202
crossref_primary_10_1007_s10911_011_9200_x
crossref_primary_10_1038_s41559_020_01355_2
crossref_primary_10_1177_107327480701400403
crossref_primary_10_2329_perio_61_127
crossref_primary_10_1186_s13058_017_0856_z
crossref_primary_10_1038_onc_2011_408
crossref_primary_10_1158_2159_8290_CD_13_0038
crossref_primary_10_1016_j_currproblcancer_2017_02_009
crossref_primary_10_1038_bjc_2011_41
crossref_primary_10_1186_s12885_019_5946_0
crossref_primary_10_3390_mps7040063
crossref_primary_10_1093_carcin_bgad071
crossref_primary_10_1007_s11606_009_1009_6
crossref_primary_10_3892_ol_2018_7836
crossref_primary_10_1634_theoncologist_2016_0135
crossref_primary_10_4251_wjgo_v12_i2_228
crossref_primary_10_1097_00002820_200312000_00001
crossref_primary_10_1111_j_1524_4741_2009_00802_x
crossref_primary_10_1177_107327481101800103
crossref_primary_10_1136_jmg_2023_109791
crossref_primary_10_1158_1055_9965_EPI_13_1279
crossref_primary_10_1016_j_ygyno_2015_06_019
crossref_primary_10_29089_paom_151573
crossref_primary_10_1002_cncr_30498
crossref_primary_10_3109_14733400500178592
crossref_primary_10_1007_s13187_013_0525_6
crossref_primary_10_1101_gr_190116_115
crossref_primary_10_1186_1471_2156_8_68
crossref_primary_10_1016_j_breast_2005_08_005
crossref_primary_10_1007_s10689_009_9267_3
crossref_primary_10_1097_AOG_0b013e3181ec5fc1
crossref_primary_10_1016_j_pec_2011_01_017
crossref_primary_10_1007_s10549_014_3063_y
crossref_primary_10_1053_j_seminoncol_2015_09_015
crossref_primary_10_1002_mgg3_2134
crossref_primary_10_1200_JCO_2005_02_9199
crossref_primary_10_4161_cc_22226
crossref_primary_10_1007_s10549_017_4635_4
crossref_primary_10_1007_s10689_017_9985_x
crossref_primary_10_1007_s12041_013_0223_5
crossref_primary_10_1155_2018_5438179
crossref_primary_10_1016_j_ejmhg_2014_01_003
crossref_primary_10_1016_S1634_7358_16_78855_3
crossref_primary_10_1016_j_femme_2014_03_004
crossref_primary_10_1007_s10549_014_3196_z
crossref_primary_10_1136_jmg_2023_109325
crossref_primary_10_1016_j_ygyno_2016_07_104
Cites_doi 10.1093/jnci/93.16.1215
10.1093/jnci/92.18.1529
10.1093/jnci/90.23.1824
10.1093/jnci/91.11.943
10.1093/jnci/94.16.1221
10.1056/NEJM199705153362001
10.1038/sj.bjc.6690008
10.1086/318181
10.1002/(SICI)1097-0215(20000601)86:5<737::AID-IJC21>3.0.CO;2-1
10.1086/318787
10.1093/jnci/91.10.882
10.1038/bjc.1998.366
10.1086/302853
10.1002/gepi.1014
10.1016/S0065-2660(01)42018-9
10.1038/ng0396-333
10.1038/378789a0
10.1016/S0140-6736(94)91578-4
10.1016/S0140-6736(98)03300-5
10.1038/ng1295-428
10.1093/jnci/91.14.1241
10.1126/science.7545954
10.1054/bjoc.2000.1407
10.1002/gepi.1370050611
10.1136/jmg.31.12.944
10.1073/pnas.051624098
10.1016/S0959-8049(00)00110-6
10.1086/301749
10.1086/302366
10.1002/(SICI)1098-2272(200002)18:2<173::AID-GEPI6>3.0.CO;2-R
10.1002/sim.4780100703
10.1038/ng0396-309
10.1038/ng0197-103
10.1097/00008571-200110000-00010
ContentType Journal Article
Copyright 2003 The American Society of Human Genetics
2003 INIST-CNRS
2003 by The American Society of Human Genetics. All rights reserved. 2003
Copyright_xml – notice: 2003 The American Society of Human Genetics
– notice: 2003 INIST-CNRS
– notice: 2003 by The American Society of Human Genetics. All rights reserved. 2003
CorporateAuthor Breastcancer-genetics
Tumörmikromiljö
Department of Clinical Sciences, Lund
Section I
Tumor microenvironment
Faculty of Medicine
Institutionen för kliniska vetenskaper, Lund
Bröstcancer-genetik
Lunds universitet
Sektion I
Medicinska fakulteten
Lund University
CorporateAuthor_xml – name: Faculty of Medicine
– name: Department of Clinical Sciences, Lund
– name: Medicinska fakulteten
– name: Tumörmikromiljö
– name: Lund University
– name: Bröstcancer-genetik
– name: Institutionen för kliniska vetenskaper, Lund
– name: Section I
– name: Breastcancer-genetics
– name: Tumor microenvironment
– name: Lunds universitet
– name: Sektion I
DBID 6I.
AAFTH
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ADTPV
AOWAS
D95
DOI 10.1086/375033
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
SwePub
SwePub Articles
SWEPUB Lunds universitet
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate BRCA1/BRCA2 Breast and Ovarian Cancer Risks
EISSN 1537-6605
EndPage 1130
ExternalDocumentID oai_portal_research_lu_se_publications_3936a3e3_1fa0_4196_934b_12960b753fb4
PMC1180265
12677558
14804286
10_1086_375033
S0002929707606405
Genre Meta-Analysis
Research Support, U.S. Gov't, P.H.S
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA063682
– fundername: NCI NIH HHS
  grantid: R01 CA63682
– fundername: NCI NIH HHS
  grantid: 1R01 CA81203
GroupedDBID ---
--K
--Z
-~X
.55
.GJ
0R~
123
1~5
23M
2WC
34R
3O-
4.4
41~
457
4G.
53G
5GY
62-
6I.
6J9
7-5
85S
AACTN
AAEDT
AAEDW
AAFTH
AAIAV
AAIKJ
AAKRW
AALRI
AAQXK
AAUCE
AAVLU
AAWTL
AAXJY
AAXUO
ABJNI
ABMAC
ABMWF
ABOCM
ABVKL
ACGFO
ACGFS
ACGOD
ACKIV
ACNCT
ACPRK
ADBBV
ADEZE
ADJPV
ADMUD
AENEX
AEXQZ
AFMIJ
AFRAH
AFTJW
AGCDD
AGHFR
AGKMS
AHMBA
AI.
AITUG
ALKID
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
ASPBG
AVWKF
AZFZN
BAWUL
C1A
CS3
D0L
DIK
E3Z
EBS
ECV
EJD
F20
F5P
FA8
FCP
FDB
FEDTE
FGOYB
GX1
HVGLF
HYE
HZ~
IH2
IHE
IXB
JIG
KQ8
L7B
M41
MVM
NCXOZ
NEJ
O-L
O9-
OHT
OK1
OZT
P2P
PQQKQ
R2-
RCE
RIG
RNS
ROL
RPM
RPZ
SES
SJN
SSZ
TN5
TR2
TWZ
UHB
UKR
UNMZH
UPT
VH1
VQA
WH7
WOQ
WQ6
X7M
XOL
ZA5
ZCA
ZCG
ZGI
ZXP
AAFWJ
AAMRU
AAYWO
AAYXX
ABDGV
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
ADVLN
ADXHL
AEUPX
AFPUW
AGCQF
AGQPQ
AIGII
AKAPO
AKBMS
AKRWK
AKYEP
APXCP
CITATION
EFKBS
IQODW
0SF
CGR
CUY
CVF
ECM
EIF
NPM
VXZ
Z5M
7X8
5PM
ADTPV
AOWAS
D95
ID FETCH-LOGICAL-c523t-2ac4f454abc64b6224bbc7d446b007434fc432a368dcc65ae8c54d17c8582bed3
IEDL.DBID IXB
ISSN 0002-9297
1537-6605
IngestDate Fri Sep 26 03:12:36 EDT 2025
Thu Aug 21 14:12:05 EDT 2025
Sat Sep 27 19:19:17 EDT 2025
Wed Feb 19 01:41:27 EST 2025
Mon Jul 21 09:11:43 EDT 2025
Tue Jul 01 02:32:08 EDT 2025
Thu Apr 24 23:12:06 EDT 2025
Fri Feb 23 02:32:22 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Family study
Pathogenesis
Risk
Breast cancer
Malignant tumor
Genetic determinism
Female genital diseases
Genetic disease
Case study
Mammary gland diseases
Ovarian diseases
Ovary
Risk factor
Mammary gland
Mutation
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c523t-2ac4f454abc64b6224bbc7d446b007434fc432a368dcc65ae8c54d17c8582bed3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
The first two authors contributed equally to this work.
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0002929707606405
PMID 12677558
PQID 73211813
PQPubID 23479
PageCount 14
ParticipantIDs swepub_primary_oai_portal_research_lu_se_publications_3936a3e3_1fa0_4196_934b_12960b753fb4
pubmedcentral_primary_oai_pubmedcentral_nih_gov_1180265
proquest_miscellaneous_73211813
pubmed_primary_12677558
pascalfrancis_primary_14804286
crossref_primary_10_1086_375033
crossref_citationtrail_10_1086_375033
elsevier_sciencedirect_doi_10_1086_375033
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2003-05-01
PublicationDateYYYYMMDD 2003-05-01
PublicationDate_xml – month: 05
  year: 2003
  text: 2003-05-01
  day: 01
PublicationDecade 2000
PublicationPlace Chicago, IL
PublicationPlace_xml – name: Chicago, IL
– name: United States
PublicationTitle American journal of human genetics
PublicationTitleAlternate Am J Hum Genet
PublicationYear 2003
Publisher Elsevier Inc
University of Chicago Press
The American Society of Human Genetics
Publisher_xml – name: Elsevier Inc
– name: University of Chicago Press
– name: The American Society of Human Genetics
References Claus, Schildkraut, Iversen, Berry, Parmigiani (bib9) 1998; 90
Wooster, Bignell, Lancaster, Swift, Seal, Mangion, Collins (bib50) 1995; 378
Ford, Easton, Bishop, Narod, Goldgar, Breast Cancer Linkage Consortium (bib17) 1994; 343
Lange, Weeks, Boehnke (bib23) 1988; 5
Hopper, Southey, Dite, Jolley, Giles, McCredie, Easton, Venter, Australian Breast Cancer Family Study (bib22) 1999; 8
Moslehi, Chu, Karlan, Fishman, Risch, Fields, Smotkin, Ben-David, Rosenblatt, Russo, Schwartz, Tung, Warner, Rosen, Friedman, Brunet, Narod (bib27) 2000; 66
Thorlacius, Struewing, Hartge, Olafsdottir, Sigvaldason, Tryggvadottir, Wacholder, Tulinius, Eyfjord (bib45) 1998; 352
Easton, Peto, Babiker (bib14) 1991; 10
Parkin, Whelan, Ferlay, Raymond, Young (bib30) 1997; vol VII
Satagopan, Offit, Foulkes, Robson, Wacholder, Eng, Karp, Begg (bib37) 2001; 10
Peto, Collins, Barfoot, Seal, Warren, Rahman, Easton, Evans, Deacon, Stratton (bib31) 1999; 91
Anton-Culver, Cohen, Gildea, Ziogas (bib4) 2000; 36
Southey, Tesoriero, Andersen, Jennings, Brown, Dite, Jenkins, Osborne, Maskiell, Porter, Giles, McCredie, Hopper, Venter (bib38) 1999; 79
Antoniou, Pharoah, McMullen, Day, Ponder, Easton (bib6) 2001; 21
Eccles, Marlow, Royle, Collins, Morton (bib16) 1994; 31
Runnebaum, Wang-Gohrke, Vesprini, Kreienberg, Lynch, Moslehi, Ghadirian, Weber, Godwin, Risch, Garber, Lerman, Olopade, Foulkes, Karlan, Warner, Rosen, Rebbeck, Tonin, Dube, Kieback, Narod (bib36) 2001; 11
Miki, Swensen, Shattuck-Eidens, Futreal, Harsham, Tavtigian, Liu (bib26) 1994; 266
Risch, McLaughlin, Cole, Rosen, Bradley, Kwan, Jack, Vesprini, Kuperstein, Abrahamson, Fan, Wong, Narod (bib35) 2001; 68
Friedman, Gayther, Kurosaki, Gordon, Noble, Casey, Ponder, Anton-Culver (bib19) 1997; 60
Muir, Waterhouse, Mack, Powell, Whelan (bib28) 1987; vol V
Basham, Lipscombe, Ward, Easton, Gayther, Ponder, Pharoah (bib7) 2002; 4
Thompson, Easton (bib43) 2001; 68
Antoniou, Gayther, Stratton, Ponder, Easton (bib5) 2000; 18
Loman, Johannsson, Kristoffersson, Olsson, Borg (bib25) 2001; 93
Rebbeck, Kantoff, Krithivas, Neuhausen, Blackwood, Godwin, Daly, Narod, Garber, Lynch, Weber, Brown (bib33) 1999; 64
Levy-Lahad, Lahad, Eisenberg, Dagan, Paperna, Kasinetz, Catane, Kaufman, Beller, Renbaum, Gershoni-Baruch (bib24) 2001; 98
Rebbeck, Wang, Kantoff, Krithivas, Neuhausen, Godwin, Daly, Narod, Brunet, Vesprini, Garber, Lynch, Weber, Brown (bib34) 2001; 61
Thompson, Easton (bib44) 2002; 11
Clerget-Darpoux (bib10) 2001; 42
Waterhouse, Muir, Correa, Powell (bib48) 1976; vol III
Eccles, Englefield, Soulby, Campbell (bib15) 1998; 77
De Benedetti, Radice, Pasini, Stagi, Pensotti, Mondini, Manoukian, Conti, Spatti, Rilke, Pierotti (bib11) 1998; 12
Parkin, Whelan, Ferlay, Raymond, Young (bib29) 1992; vol VI
Gayther, Mangion, Russell, Seal, Barfoot, Ponder, Stratton, Easton (bib20) 1997; 15
Ford, Easton, Stratton, Narod, Goldgar, Devilee, Bishop (bib18) 1998; 62
Gayther, Warren, Mazoyer, Russell, Harrington, Chiano, Seal, Hamoudi, van Rensburg, Dunning, Love, Evans, Easton, Clayton, Stratton, Ponder (bib21) 1995; 11
Anglian Breast Cancer Study Group (bib3) 2000; 83
Syrjäkoski, Vahteristo, Eerola, Tamminen, Kivinummi, Sarantaus, Holli, Blomqvist, Kallioniemi, Kainu, Nevanlinna (bib40) 2000; 92
Begg (bib8) 2002; 94
Tang, Pang, Yeo, Choy, Lam, Suen, Law, King, Johnson, Hjelm (bib41) 1999; 91
Phelan, Rebbeck, Weber, Devilee, Ruttledge, Lynch, Lenoir, Stratton, Easton, Ponder, Cannon-Albright, Larsson, Goldgar, Narod (bib32) 1996; 12
Struewing, Hartge, Wacholder, Baker, Berlin, McAdams, Timmerman, Brody, Tucker (bib39) 1997; 336
Waterhouse, Muir, Shanmurgaratnam, Powell (bib49) 1982; vol IV
Van Der Looij, Szabo, Besznyak, Liszka, Csokay, Pulay, Toth, Devilee, King, Olah (bib46) 2000; 86
Easton, Bishop, Ford, Crockford, Breast Cancer Linkage Consortium (bib12) 1993; 52
Easton, Ford, Bishop, Breast Cancer Linkage Consortium (bib13) 1995; 56
Tavtigian, Simard, Rommens, Couch, Shattuck Eidens, Neuhausen, Merajver (bib42) 1996; 12
Warner, Foulkes, Goodwin, Meschino, Blondal, Paterson, Ozcelik, Goss, Allingham-Hawkins, Hamel, Di Prospero, Contiga, Serruya, Klein, Moslehi, Honeyford, Liede, Glendon, Brunet, Narod (bib47) 1999; 91
Antoniou (10.1086/375033_bib5) 2000; 18
Claus (10.1086/375033_bib9) 1998; 90
Phelan (10.1086/375033_bib32) 1996; 12
Syrjäkoski (10.1086/375033_bib40) 2000; 92
Friedman (10.1086/375033_bib19) 1997; 60
Tavtigian (10.1086/375033_bib42) 1996; 12
Waterhouse (10.1086/375033_bib48) 1976; vol III
Easton (10.1086/375033_bib12) 1993; 52
Muir (10.1086/375033_bib28) 1987; vol V
Satagopan (10.1086/375033_bib37) 2001; 10
Wooster (10.1086/375033_bib50) 1995; 378
Warner (10.1086/375033_bib47) 1999; 91
Loman (10.1086/375033_bib25) 2001; 93
Thorlacius (10.1086/375033_bib45) 1998; 352
Ford (10.1086/375033_bib18) 1998; 62
Southey (10.1086/375033_bib38) 1999; 79
Gayther (10.1086/375033_bib20) 1997; 15
Miki (10.1086/375033_bib26) 1994; 266
Parkin (10.1086/375033_bib29) 1992; vol VI
Eccles (10.1086/375033_bib15) 1998; 77
Thompson (10.1086/375033_bib43) 2001; 68
Parkin (10.1086/375033_bib30) 1997; vol VII
Lange (10.1086/375033_bib23) 1988; 5
Antoniou (10.1086/375033_bib6) 2001; 21
Begg (10.1086/375033_bib8) 2002; 94
Clerget-Darpoux (10.1086/375033_bib10) 2001; 42
Peto (10.1086/375033_bib31) 1999; 91
Basham (10.1086/375033_bib7) 2002; 4
Rebbeck (10.1086/375033_bib34) 2001; 61
Runnebaum (10.1086/375033_bib36) 2001; 11
Easton (10.1086/375033_bib14) 1991; 10
Gayther (10.1086/375033_bib21) 1995; 11
Risch (10.1086/375033_bib35) 2001; 68
De Benedetti (10.1086/375033_bib11) 1998; 12
Hopper (10.1086/375033_bib22) 1999; 8
Ford (10.1086/375033_bib17) 1994; 343
Struewing (10.1086/375033_bib39) 1997; 336
Waterhouse (10.1086/375033_bib49) 1982; vol IV
Moslehi (10.1086/375033_bib27) 2000; 66
Rebbeck (10.1086/375033_bib33) 1999; 64
Thompson (10.1086/375033_bib44) 2002; 11
Tang (10.1086/375033_bib41) 1999; 91
Eccles (10.1086/375033_bib16) 1994; 31
Van Der Looij (10.1086/375033_bib46) 2000; 86
Anglian Breast Cancer Study Group (10.1086/375033_bib3) 2000; 83
Anton-Culver (10.1086/375033_bib4) 2000; 36
Easton (10.1086/375033_bib13) 1995; 56
Levy-Lahad (10.1086/375033_bib24) 2001; 98
10995809 - J Natl Cancer Inst. 2000 Sep 20;92(18):1529-31
8524414 - Nature. 1995 Dec 21-28;378(6559):789-92
11170890 - Am J Hum Genet. 2001 Feb;68(2):410-9
7493024 - Nat Genet. 1995 Dec;11(4):428-33
10359546 - J Natl Cancer Inst. 1999 Jun 2;91(11):943-9
11037317 - Adv Genet. 2001;42:115-24
10797299 - Int J Cancer. 2000 Jun 1;86(5):737-40
11879560 - Breast Cancer Res. 2002;4(1):R2
1652152 - Stat Med. 1991 Jul;10(7):1025-35
9145676 - N Engl J Med. 1997 May 15;336(20):1401-8
8988179 - Nat Genet. 1997 Jan;15(1):103-5
10882857 - Eur J Cancer. 2000 Jun;36(10):1200-8
10739756 - Am J Hum Genet. 2000 Apr;66(4):1259-72
11248061 - Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3232-6
11352856 - Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):467-73
8589730 - Nat Genet. 1996 Mar;12(3):333-7
9012404 - Am J Hum Genet. 1997 Feb;60(2):313-9
9802270 - Lancet. 1998 Oct 24;352(9137):1337-9
10642429 - Genet Epidemiol. 2000 Feb;18(2):173-90
8589723 - Nat Genet. 1996 Mar;12(3):309-11
12189225 - J Natl Cancer Inst. 2002 Aug 21;94(16):1221-6
10660329 - Hum Mutat. 1998;12(3):215
9649133 - Br J Cancer. 1998 Jun;77(12):2199-203
10498392 - Cancer Epidemiol Biomarkers Prev. 1999 Sep;8(9):741-7
3061869 - Genet Epidemiol. 1988;5(6):471-2
10205268 - Am J Hum Genet. 1999 May;64(5):1371-7
10408690 - Br J Cancer. 1999 Jan;79(1):34-9
11443730 - Genet Epidemiol. 2001 Jul;21(1):1-18
10340909 - J Natl Cancer Inst. 1999 May 19;91(10):882-5
11504767 - J Natl Cancer Inst. 2001 Aug 15;93(16):1215-23
9497246 - Am J Hum Genet. 1998 Mar;62(3):676-89
10413426 - J Natl Cancer Inst. 1999 Jul 21;91(14):1241-7
11044354 - Br J Cancer. 2000 Nov;83(10):1301-8
11179017 - Am J Hum Genet. 2001 Mar;68(3):700-10
11454686 - Cancer Res. 2001 Jul 15;61(14):5420-4
11668223 - Pharmacogenetics. 2001 Oct;11(7):635-8
7907678 - Lancet. 1994 Mar 19;343(8899):692-5
11927492 - Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):329-36
Am J Hum Genet. 2003 Sep;73(3):709
8460634 - Am J Hum Genet. 1993 Apr;52(4):678-701
7545954 - Science. 1994 Oct 7;266(5182):66-71
7825587 - Am J Hum Genet. 1995 Jan;56(1):265-71
7891376 - J Med Genet. 1994 Dec;31(12):944-9
9839523 - J Natl Cancer Inst. 1998 Dec 2;90(23):1824-9
References_xml – volume: 42
  start-page: 115
  year: 2001
  end-page: 124
  ident: bib10
  article-title: Extension of the lod score: the mod score
  publication-title: Adv Genet
– volume: 266
  start-page: 66
  year: 1994
  end-page: 71
  ident: bib26
  article-title: A strong candidate for the 17 linked breast and ovarian cancer susceptibility gene
  publication-title: Science
– volume: 93
  start-page: 1215
  year: 2001
  end-page: 1223
  ident: bib25
  article-title: Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer
  publication-title: J Natl Cancer Inst
– volume: 90
  start-page: 1824
  year: 1998
  end-page: 1829
  ident: bib9
  article-title: Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history
  publication-title: J Natl Cancer Inst
– volume: 4
  start-page: R2.1
  year: 2002
  end-page: R2.4
  ident: bib7
  publication-title: Breast Cancer Res
– volume: 378
  start-page: 789
  year: 1995
  end-page: 792
  ident: bib50
  article-title: Identification of the breast cancer susceptibility gene BRCA2
  publication-title: Nature
– volume: 21
  start-page: 1
  year: 2001
  end-page: 18
  ident: bib6
  article-title: Evidence for further breast cancer susceptibility genes in addition to
  publication-title: Genet Epidemiol
– volume: 12
  start-page: 333
  year: 1996
  end-page: 337
  ident: bib42
  article-title: The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds
  publication-title: Nat Genet
– volume: 66
  start-page: 1259
  year: 2000
  end-page: 1272
  ident: bib27
  publication-title: Am J Hum Genet
– volume: 10
  start-page: 467
  year: 2001
  end-page: 473
  ident: bib37
  article-title: The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 36
  start-page: 1200
  year: 2000
  end-page: 1208
  ident: bib4
  article-title: Characteristics of
  publication-title: Eur J Cancer
– volume: vol V
  year: 1987
  ident: bib28
  publication-title: Cancer incidence in five continents
– volume: 79
  start-page: 34
  year: 1999
  end-page: 39
  ident: bib38
  publication-title: Br J Cancer
– volume: 86
  start-page: 737
  year: 2000
  end-page: 740
  ident: bib46
  article-title: Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary
  publication-title: Int J Cancer
– volume: 56
  start-page: 265
  year: 1995
  end-page: 271
  ident: bib13
  article-title: Breast and ovarian cancer incidence in
  publication-title: Am J Hum Genet
– volume: vol VII
  year: 1997
  ident: bib30
  publication-title: Cancer incidence in five continents
– volume: 91
  start-page: 943
  year: 1999
  end-page: 949
  ident: bib31
  article-title: Prevalence of
  publication-title: J Natl Cancer Inst
– volume: 94
  start-page: 1221
  year: 2002
  end-page: 1226
  ident: bib8
  article-title: On the use of familial aggregation in population-based case probands for calculating penetrance
  publication-title: J Natl Cancer Inst
– volume: 352
  start-page: 1337
  year: 1998
  end-page: 1339
  ident: bib45
  article-title: Population-based study of risk of breast cancer in carriers of BRCA2 mutation
  publication-title: Lancet
– volume: 5
  start-page: 471
  year: 1988
  end-page: 472
  ident: bib23
  article-title: Programs for pedigree analysis: MENDEL, FISHER, and dGENE
  publication-title: Genet Epidemiol
– volume: 68
  start-page: 410
  year: 2001
  end-page: 419
  ident: bib43
  article-title: Variation in cancer risks, by mutation position, in BRCA2 mutation carriers
  publication-title: Am J Hum Genet
– volume: 83
  start-page: 1301
  year: 2000
  end-page: 1308
  ident: bib3
  article-title: Prevalence and penetrance of
  publication-title: Br J Cancer
– volume: 91
  start-page: 1241
  year: 1999
  end-page: 1247
  ident: bib47
  article-title: Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer
  publication-title: J Natl Cancer Inst
– volume: 343
  start-page: 692
  year: 1994
  end-page: 695
  ident: bib17
  article-title: Risks of cancer in
  publication-title: Lancet
– volume: 11
  start-page: 428
  year: 1995
  end-page: 433
  ident: bib21
  article-title: Germline mutations of the
  publication-title: Nat Genet
– volume: 52
  start-page: 678
  year: 1993
  end-page: 701
  ident: bib12
  article-title: Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families
  publication-title: Am J Hum Genet
– volume: 61
  start-page: 5420
  year: 2001
  end-page: 5424
  ident: bib34
  article-title: Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history
  publication-title: Cancer Res
– volume: 62
  start-page: 676
  year: 1998
  end-page: 689
  ident: bib18
  article-title: Genetic heterogeneity and penetrance analysis of the
  publication-title: Am J Hum Genet
– volume: 8
  start-page: 741
  year: 1999
  end-page: 747
  ident: bib22
  article-title: Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 11
  start-page: 635
  year: 2001
  end-page: 638
  ident: bib36
  article-title: Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives
  publication-title: Pharmacogenetics
– volume: vol VI
  year: 1992
  ident: bib29
  publication-title: Cancer incidence in five continents
– volume: 98
  start-page: 3232
  year: 2001
  end-page: 3236
  ident: bib24
  article-title: A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers
  publication-title: Proc Natl Acad Sci USA
– volume: 18
  start-page: 173
  year: 2000
  end-page: 190
  ident: bib5
  article-title: Risk models for familial breast and ovarian cancer
  publication-title: Genet Epidemiol
– volume: 31
  start-page: 944
  year: 1994
  end-page: 949
  ident: bib16
  article-title: Genetic epidemiology of early onset breast cancer
  publication-title: J Med Genet
– volume: 11
  start-page: 329
  year: 2002
  end-page: 336
  ident: bib44
  article-title: Variation in BRCA1 cancer risks by mutation position
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 91
  start-page: 882
  year: 1999
  end-page: 885
  ident: bib41
  article-title: Prevalence of mutations in the BRCA1 gene among Chinese patients with breast cancer
  publication-title: J Natl Cancer Inst
– volume: 12
  start-page: 215
  year: 1998
  ident: bib11
  article-title: Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients: mutation in brief no. 178. Online
  publication-title: Hum Mutat
– volume: 336
  start-page: 1401
  year: 1997
  end-page: 1408
  ident: bib39
  article-title: The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
  publication-title: N Engl J Med
– volume: 77
  start-page: 2199
  year: 1998
  end-page: 2203
  ident: bib15
  publication-title: Br J Cancer
– volume: 60
  start-page: 313
  year: 1997
  end-page: 319
  ident: bib19
  article-title: Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population
  publication-title: Am J Hum Genet
– volume: 68
  start-page: 700
  year: 2001
  end-page: 710
  ident: bib35
  article-title: Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer
  publication-title: Am J Hum Genet
– volume: 92
  start-page: 1529
  year: 2000
  end-page: 1531
  ident: bib40
  article-title: Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients
  publication-title: J Natl Cancer Inst
– volume: 15
  start-page: 103
  year: 1997
  end-page: 105
  ident: bib20
  article-title: Variation of risks of breast and ovarian cancer associated with different germline mutations of the
  publication-title: Nat Genet
– volume: 12
  start-page: 309
  year: 1996
  end-page: 311
  ident: bib32
  article-title: Ovarian cancer risk in
  publication-title: Nat Genet
– volume: 64
  start-page: 1371
  year: 1999
  end-page: 1377
  ident: bib33
  article-title: Modification of
  publication-title: Am J Hum Genet
– volume: 10
  start-page: 1025
  year: 1991
  end-page: 1035
  ident: bib14
  article-title: Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group
  publication-title: Stat Med
– volume: vol III
  year: 1976
  ident: bib48
  publication-title: Cancer incidence in five continents
– volume: vol IV
  year: 1982
  ident: bib49
  publication-title: Cancer incidence in five continents
– volume: 93
  start-page: 1215
  year: 2001
  ident: 10.1086/375033_bib25
  article-title: Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/93.16.1215
– volume: 92
  start-page: 1529
  year: 2000
  ident: 10.1086/375033_bib40
  article-title: Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/92.18.1529
– volume: 90
  start-page: 1824
  year: 1998
  ident: 10.1086/375033_bib9
  article-title: Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/90.23.1824
– volume: vol IV
  year: 1982
  ident: 10.1086/375033_bib49
– volume: 60
  start-page: 313
  year: 1997
  ident: 10.1086/375033_bib19
  article-title: Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population
  publication-title: Am J Hum Genet
– volume: vol VII
  year: 1997
  ident: 10.1086/375033_bib30
– volume: 61
  start-page: 5420
  year: 2001
  ident: 10.1086/375033_bib34
  article-title: Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history
  publication-title: Cancer Res
– volume: 91
  start-page: 943
  year: 1999
  ident: 10.1086/375033_bib31
  article-title: Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/91.11.943
– volume: vol V
  year: 1987
  ident: 10.1086/375033_bib28
– volume: 94
  start-page: 1221
  year: 2002
  ident: 10.1086/375033_bib8
  article-title: On the use of familial aggregation in population-based case probands for calculating penetrance
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/94.16.1221
– volume: 336
  start-page: 1401
  year: 1997
  ident: 10.1086/375033_bib39
  article-title: The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199705153362001
– volume: 12
  start-page: 215
  year: 1998
  ident: 10.1086/375033_bib11
  article-title: Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients: mutation in brief no. 178. Online
  publication-title: Hum Mutat
– volume: vol VI
  year: 1992
  ident: 10.1086/375033_bib29
– volume: 79
  start-page: 34
  year: 1999
  ident: 10.1086/375033_bib38
  article-title: BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6690008
– volume: 8
  start-page: 741
  year: 1999
  ident: 10.1086/375033_bib22
  article-title: Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 68
  start-page: 410
  year: 2001
  ident: 10.1086/375033_bib43
  article-title: Variation in cancer risks, by mutation position, in BRCA2 mutation carriers
  publication-title: Am J Hum Genet
  doi: 10.1086/318181
– volume: 86
  start-page: 737
  year: 2000
  ident: 10.1086/375033_bib46
  article-title: Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary
  publication-title: Int J Cancer
  doi: 10.1002/(SICI)1097-0215(20000601)86:5<737::AID-IJC21>3.0.CO;2-1
– volume: 68
  start-page: 700
  year: 2001
  ident: 10.1086/375033_bib35
  article-title: Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer
  publication-title: Am J Hum Genet
  doi: 10.1086/318787
– volume: 91
  start-page: 882
  year: 1999
  ident: 10.1086/375033_bib41
  article-title: Prevalence of mutations in the BRCA1 gene among Chinese patients with breast cancer
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/91.10.882
– volume: 4
  start-page: R2.1
  year: 2002
  ident: 10.1086/375033_bib7
  article-title: BRCA1 and BRCA2 mutations in a population based study of male breast cancer
  publication-title: Breast Cancer Res
– volume: 77
  start-page: 2199
  year: 1998
  ident: 10.1086/375033_bib15
  article-title: BRCA1 mutations in southern England
  publication-title: Br J Cancer
  doi: 10.1038/bjc.1998.366
– volume: 56
  start-page: 265
  year: 1995
  ident: 10.1086/375033_bib13
  article-title: Breast and ovarian cancer incidence in BRCA1-mutation carriers
  publication-title: Am J Hum Genet
– volume: 66
  start-page: 1259
  year: 2000
  ident: 10.1086/375033_bib27
  article-title: BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer
  publication-title: Am J Hum Genet
  doi: 10.1086/302853
– volume: 21
  start-page: 1
  year: 2001
  ident: 10.1086/375033_bib6
  article-title: Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population based study
  publication-title: Genet Epidemiol
  doi: 10.1002/gepi.1014
– volume: 42
  start-page: 115
  year: 2001
  ident: 10.1086/375033_bib10
  article-title: Extension of the lod score: the mod score
  publication-title: Adv Genet
  doi: 10.1016/S0065-2660(01)42018-9
– volume: 12
  start-page: 333
  year: 1996
  ident: 10.1086/375033_bib42
  article-title: The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds
  publication-title: Nat Genet
  doi: 10.1038/ng0396-333
– volume: vol III
  year: 1976
  ident: 10.1086/375033_bib48
– volume: 378
  start-page: 789
  year: 1995
  ident: 10.1086/375033_bib50
  article-title: Identification of the breast cancer susceptibility gene BRCA2
  publication-title: Nature
  doi: 10.1038/378789a0
– volume: 343
  start-page: 692
  year: 1994
  ident: 10.1086/375033_bib17
  article-title: Risks of cancer in BRCA1 mutation carriers
  publication-title: Lancet
  doi: 10.1016/S0140-6736(94)91578-4
– volume: 10
  start-page: 467
  year: 2001
  ident: 10.1086/375033_bib37
  article-title: The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 352
  start-page: 1337
  year: 1998
  ident: 10.1086/375033_bib45
  article-title: Population-based study of risk of breast cancer in carriers of BRCA2 mutation
  publication-title: Lancet
  doi: 10.1016/S0140-6736(98)03300-5
– volume: 11
  start-page: 428
  year: 1995
  ident: 10.1086/375033_bib21
  article-title: Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation
  publication-title: Nat Genet
  doi: 10.1038/ng1295-428
– volume: 11
  start-page: 329
  year: 2002
  ident: 10.1086/375033_bib44
  article-title: Variation in BRCA1 cancer risks by mutation position
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 91
  start-page: 1241
  year: 1999
  ident: 10.1086/375033_bib47
  article-title: Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/91.14.1241
– volume: 266
  start-page: 66
  year: 1994
  ident: 10.1086/375033_bib26
  article-title: A strong candidate for the 17 linked breast and ovarian cancer susceptibility gene BRCA1
  publication-title: Science
  doi: 10.1126/science.7545954
– volume: 52
  start-page: 678
  year: 1993
  ident: 10.1086/375033_bib12
  article-title: Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families
  publication-title: Am J Hum Genet
– volume: 83
  start-page: 1301
  year: 2000
  ident: 10.1086/375033_bib3
  article-title: Prevalence and penetrance of BRCA1 and BRCA2 in a population based series of breast cancer cases
  publication-title: Br J Cancer
  doi: 10.1054/bjoc.2000.1407
– volume: 5
  start-page: 471
  year: 1988
  ident: 10.1086/375033_bib23
  article-title: Programs for pedigree analysis: MENDEL, FISHER, and dGENE
  publication-title: Genet Epidemiol
  doi: 10.1002/gepi.1370050611
– volume: 31
  start-page: 944
  year: 1994
  ident: 10.1086/375033_bib16
  article-title: Genetic epidemiology of early onset breast cancer
  publication-title: J Med Genet
  doi: 10.1136/jmg.31.12.944
– volume: 98
  start-page: 3232
  year: 2001
  ident: 10.1086/375033_bib24
  article-title: A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.051624098
– volume: 36
  start-page: 1200
  year: 2000
  ident: 10.1086/375033_bib4
  article-title: Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer
  publication-title: Eur J Cancer
  doi: 10.1016/S0959-8049(00)00110-6
– volume: 62
  start-page: 676
  year: 1998
  ident: 10.1086/375033_bib18
  article-title: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
  publication-title: Am J Hum Genet
  doi: 10.1086/301749
– volume: 64
  start-page: 1371
  year: 1999
  ident: 10.1086/375033_bib33
  article-title: Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat
  publication-title: Am J Hum Genet
  doi: 10.1086/302366
– volume: 18
  start-page: 173
  year: 2000
  ident: 10.1086/375033_bib5
  article-title: Risk models for familial breast and ovarian cancer
  publication-title: Genet Epidemiol
  doi: 10.1002/(SICI)1098-2272(200002)18:2<173::AID-GEPI6>3.0.CO;2-R
– volume: 10
  start-page: 1025
  year: 1991
  ident: 10.1086/375033_bib14
  article-title: Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group
  publication-title: Stat Med
  doi: 10.1002/sim.4780100703
– volume: 12
  start-page: 309
  year: 1996
  ident: 10.1086/375033_bib32
  article-title: Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus
  publication-title: Nat Genet
  doi: 10.1038/ng0396-309
– volume: 15
  start-page: 103
  year: 1997
  ident: 10.1086/375033_bib20
  article-title: Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene
  publication-title: Nat Genet
  doi: 10.1038/ng0197-103
– volume: 11
  start-page: 635
  year: 2001
  ident: 10.1086/375033_bib36
  article-title: Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives
  publication-title: Pharmacogenetics
  doi: 10.1097/00008571-200110000-00010
– reference: 8988179 - Nat Genet. 1997 Jan;15(1):103-5
– reference: 11179017 - Am J Hum Genet. 2001 Mar;68(3):700-10
– reference: - Am J Hum Genet. 2003 Sep;73(3):709
– reference: 10359546 - J Natl Cancer Inst. 1999 Jun 2;91(11):943-9
– reference: 8460634 - Am J Hum Genet. 1993 Apr;52(4):678-701
– reference: 7493024 - Nat Genet. 1995 Dec;11(4):428-33
– reference: 9145676 - N Engl J Med. 1997 May 15;336(20):1401-8
– reference: 8524414 - Nature. 1995 Dec 21-28;378(6559):789-92
– reference: 8589723 - Nat Genet. 1996 Mar;12(3):309-11
– reference: 7825587 - Am J Hum Genet. 1995 Jan;56(1):265-71
– reference: 10642429 - Genet Epidemiol. 2000 Feb;18(2):173-90
– reference: 12189225 - J Natl Cancer Inst. 2002 Aug 21;94(16):1221-6
– reference: 8589730 - Nat Genet. 1996 Mar;12(3):333-7
– reference: 11037317 - Adv Genet. 2001;42:115-24
– reference: 10660329 - Hum Mutat. 1998;12(3):215
– reference: 11668223 - Pharmacogenetics. 2001 Oct;11(7):635-8
– reference: 9649133 - Br J Cancer. 1998 Jun;77(12):2199-203
– reference: 10995809 - J Natl Cancer Inst. 2000 Sep 20;92(18):1529-31
– reference: 11504767 - J Natl Cancer Inst. 2001 Aug 15;93(16):1215-23
– reference: 11879560 - Breast Cancer Res. 2002;4(1):R2
– reference: 11454686 - Cancer Res. 2001 Jul 15;61(14):5420-4
– reference: 10498392 - Cancer Epidemiol Biomarkers Prev. 1999 Sep;8(9):741-7
– reference: 10739756 - Am J Hum Genet. 2000 Apr;66(4):1259-72
– reference: 11248061 - Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3232-6
– reference: 11170890 - Am J Hum Genet. 2001 Feb;68(2):410-9
– reference: 1652152 - Stat Med. 1991 Jul;10(7):1025-35
– reference: 7891376 - J Med Genet. 1994 Dec;31(12):944-9
– reference: 9802270 - Lancet. 1998 Oct 24;352(9137):1337-9
– reference: 7907678 - Lancet. 1994 Mar 19;343(8899):692-5
– reference: 11044354 - Br J Cancer. 2000 Nov;83(10):1301-8
– reference: 7545954 - Science. 1994 Oct 7;266(5182):66-71
– reference: 9012404 - Am J Hum Genet. 1997 Feb;60(2):313-9
– reference: 9497246 - Am J Hum Genet. 1998 Mar;62(3):676-89
– reference: 11927492 - Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):329-36
– reference: 3061869 - Genet Epidemiol. 1988;5(6):471-2
– reference: 10413426 - J Natl Cancer Inst. 1999 Jul 21;91(14):1241-7
– reference: 10797299 - Int J Cancer. 2000 Jun 1;86(5):737-40
– reference: 11443730 - Genet Epidemiol. 2001 Jul;21(1):1-18
– reference: 10408690 - Br J Cancer. 1999 Jan;79(1):34-9
– reference: 9839523 - J Natl Cancer Inst. 1998 Dec 2;90(23):1824-9
– reference: 10205268 - Am J Hum Genet. 1999 May;64(5):1371-7
– reference: 10882857 - Eur J Cancer. 2000 Jun;36(10):1200-8
– reference: 10340909 - J Natl Cancer Inst. 1999 May 19;91(10):882-5
– reference: 11352856 - Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):467-73
SSID ssj0011803
Score 2.4152305
SecondaryResourceType review_article
Snippet Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the average magnitude of these risks is uncertain and may depend on...
Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the average magnitude of these risks is uncertain and may depend on...
Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the average magnitude of these risks is uncertain and may depend on...
SourceID swepub
pubmedcentral
proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1117
SubjectTerms Adult
Age Distribution
Aged
Basic Medicine
Biological and medical sciences
Breast Neoplasms - epidemiology
Breast Neoplasms - genetics
Cohort Studies
Family
Female
Female genital diseases
Genes, BRCA1
Genes, BRCA2
Genetic Testing - statistics & numerical data
Global Health
Gynecology. Andrology. Obstetrics
Heterozygote
Humans
Incidence
Male
Medical and Health Sciences
Medical Genetics and Genomics (including Gene Therapy)
Medical sciences
Medicin och hälsovetenskap
Medicinsk genetik och genomik (Här ingår: Genterapi)
Medicinska och farmaceutiska grundvetenskaper
Middle Aged
Mutation
Ovarian Neoplasms - epidemiology
Ovarian Neoplasms - genetics
Pedigree
Risk
Risk Assessment
Tumors
Title Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
URI https://dx.doi.org/10.1086/375033
https://www.ncbi.nlm.nih.gov/pubmed/12677558
https://www.proquest.com/docview/73211813
https://pubmed.ncbi.nlm.nih.gov/PMC1180265
Volume 72
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier Free Content
  customDbUrl:
  eissn: 1537-6605
  dateEnd: 20250330
  omitProxy: true
  ssIdentifier: ssj0011803
  issn: 1537-6605
  databaseCode: IXB
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1537-6605
  dateEnd: 20250330
  omitProxy: true
  ssIdentifier: ssj0011803
  issn: 1537-6605
  databaseCode: DIK
  dateStart: 19490101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1537-6605
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0011803
  issn: 1537-6605
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1537-6605
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0011803
  issn: 1537-6605
  databaseCode: AKRWK
  dateStart: 19970601
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVAQN
  databaseName: PubMed Central (Free e-resource, activated by CARLI)
  customDbUrl:
  eissn: 1537-6605
  dateEnd: 20250330
  omitProxy: true
  ssIdentifier: ssj0011803
  issn: 1537-6605
  databaseCode: RPM
  dateStart: 19490101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swEBelMBiMse9lH9k9bA97MLUtWbL3lmQr3UY3KAuEvQhJlqlpcUKcDPo_9Y_sSbLTmmwPezPWyRbS6XSnu_sdIe_LUjMUAUVUVYmOmMKdXsSWR1RTnphCxUy5q4HTH_xkzr4tssUBmfW5MC6sspP9QaZ7ad29Oepm82hV1y7HN07xcBfOt8SZxzGlTPgkvsV050lI8pj2KrCjvlNfiHof3r8OpAcr1eI0VaG-xd8U0P04ygHaqD-hjh-Rh51qCZMw-sfkwDZPyL1QbPLqKbmeINei9ICzur1oYVnB1AWkb0A1Jfz8gzazamDmmGAN_aLZEtxFLUzPZpMElmv_kMLpNjjwW_hsnRMCyWrXt7XgbttsC3OX6B5aUCuGUF4DAibJ1SeYAMohtMmxuUdFcQNKU-jiGp-R-fGXX7OTqKvVEBk0ZTdRqgyrWMaUNpxpjoqB1kaUaGxqr6WwyjCaKsrz0hieKZubjJWJMHmWp9qW9Dk5bJaNfUkAKUtRVrEwOmbGsDwTilfaUmq50jkbkQ_9gknTAZm7ehqX0jvUcy7Dwo7Iux3dKkB37FF87NdbDphO4nmyRzseMMTtJ1nu7E6Ov-s5ROIWdX4X1djltpWCpi69Fz_xIvDLbd-UC5Fl-YiIASftCBz497Clqc89CLiH7uPZiPwOPDfs4k032eFFncvLrWytXN25CJa0oFxRS2VSqVgyFMSyoEzjkNCm1WjEVpq9-o_5eU3u-zhHHwv6hhxu1lv7FvW1jR6jpfL1-9hvyxtBSEIe
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Nb9MwFLemIQQSQnyO8rG9Axw4REtix0m4tYWpg3VI0ypVXCzbcbSIKa2aFmn_E38kz3bSLSocuEXxc2LZz8_vy79HyPuiUAxFQB6UZaQCJnGn56HhAVWURzqXIZPWNTA955MZ-zpP5ntk3N2FsWmVrez3Mt1J6_bNcTubx8uqsnd8wxgP99TGljizOKb3UBsIbV7X6Xy0DSVEWUg7HdiS3ykwRF0Q718n0qOlbHCeSl_g4m8a6G4iZQ9u1B1RJ0_I41a3hKEf_lOyZ-pn5L6vNnnznPweItui-ICLqvnZwKKEkc1IX4OsC_j-C41mWcPYcsEKulUzBVhPLYwuxsMIFiv3EMN04yP4DXw2NgqBZJXt2xiw7jbTwMzedPctqBaDr68BHpTk5hMMAQURGuXY3MGi2AHFMbSJjS_I7OTL5XgStMUaAo227DqIpWYlS5hUmjPFUTNQSqcFWpvKqSms1IzGkvKs0Jon0mQ6YUWU6izJYmUK-pLs14vavCKAlEValGGqVci0ZlmSSl4qQ6nhUmVsQD50CyZ0i2RuC2pcCxdRz7jwCzsgR1u6pcfu2KH42K236HGdwANlh_awxxC3n2SZNTw5_q7jEIF71AZeZG0Wm0akNLb3e_ETB55fbvvGPE2TJBuQtMdJWwKL_t1vqasrhwLusPt4MiA_PM_1uzjbTbSAUVfieiMaI5Z3PMGC5pRLaqiIShkKhpJY5JQpHBIatQqt2FKx1_8xP0fkweRyeibOTs-_vSEPXdKjSwx9S_bXq415h8rbWh26zfkH02BERg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Average+risks+of+breast+and+ovarian+cancer+associated+with+BRCA1+or+BRCA2+mutations+detected+in+case+series+unselected+for+family+history%3A+A+combined+analysis+of+22+studies&rft.jtitle=American+journal+of+human+genetics&rft.au=ANTONIOU%2C+A&rft.au=PHAROAB%2C+P.+D.+P&rft.au=PASINI%2C+B&rft.au=RADICE%2C+P&rft.date=2003-05-01&rft.pub=University+of+Chicago+Press&rft.issn=0002-9297&rft.volume=72&rft.issue=5&rft.spage=1117&rft.epage=1130&rft_id=info:doi/10.1086%2F375033&rft.externalDBID=n%2Fa&rft.externalDocID=14804286
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9297&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9297&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9297&client=summon